パーフェクトマスター脳血管内治療　第3版

出版社： メジカルビュー社
著者：
発行日： 2021-05-20
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784758318549
電子書籍版： 2021-05-20 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

最新の情報を盛り込んでアップデート，脳血管内治療の専門医をめざす医師必携！
脳血管内治療の基礎から実際までを網羅した待望の第3版。
進歩が著しい治療技術，機械器具の最新情報を「Cutting-edge Knowledge」として紹介し，また押さえておきたい難しい手技を「Technical tips」で解説。脳血管内治療の専門医を目指す医師の教科書として役立つ書籍となっている。

目次

  • I　医療倫理とインフォームド・コンセント
    　職業倫理とインフォームド・コンセント

    II　血管解剖：治療に必要な血管走行－確実に，正確に理解する－
    　大動脈弓～頚部
    　頭蓋底部～頭蓋内

    III　画像診断：撮る，診る，読む　－診断を確実に行うために－
    　血管造影，CT，MRI
    　【Cutting-edge Knowledge】脳動脈瘤治療におけるCFDの役割
    　超音波診断
    　SPECT，PET検査

    IV　脳血管内治療：機器・管理編　－操作を行う前に－
    　脳血管内治療の術前・術後管理
    　【Cutting-edge Knowledge】抗血小板薬をめぐる話題
    　血管造影装置と放射線防護
    　デバイスとセットアップ
    　【Cutting-edge Knowledge】ハイブリッド手術室と脳血管内治療

    V　脳血管内治療：手技編　－基本手技はマスターしているか？－
    　ガイディングカテーテルの基本手技
    　【Cutting-edge Knowledge】Snuffbox approach：
    　　　新しい遠位橈骨動脈（snuffbox）　カニュレーション法を用いた脳血管内治療
    　【Technical Tips】穿刺部合併症とトラブルシューティング
    　マイクロカテーテルの基本手技
    　デタッチャブルコイルの基本手技
    　【Cutting-edge Knowledge】Hydrogel coilの海外データと本邦データ
    　【Technical Tips】迷入コイルの回収：standardとvariation
    　ネックブリッジステントの基本手技
    　【Technical Tips】ネックブリッジステントの滑落とトラブルシューティング
    　再開通デバイスの基本手技

    VI　疾患の特性と実際の治療法 －基本手技の応用編－
    　脳動脈瘤：破裂脳動脈瘤に対する瘤内塞栓術
    　脳動脈瘤：未破裂脳動脈瘤に対する瘤内塞栓術
    　【Cutting-edge Knowledge】脳動脈瘤コイル塞栓促進用補綴材PulseRider
    　【Cutting-edge Knowledge】新しい瘤内塞栓器具WEB
    　【Cutting-edge Knowledge】
    　　　Fetal type PcomAが動脈瘤のドームより分岐している症例に対する瘤内塞栓術
    　脳動脈瘤：大・巨大脳動脈瘤に対する治療戦略
    　【Cutting-edge Knowledge】
    　　　脳 動脈瘤に対するフローダイバーター治療の現況と新規デバイス
    　【Cutting-edge Knowledge】新しいフローダイバーターの登場：FRED & FRED Jr.
    　脳動脈瘤：解離性脳動脈瘤の血管内治療
    　【Cutting-edge Knowledge】頭蓋内内頚動脈解離に対する血管内治療
    　脳動静脈奇形：血管内治療のための知っておくべき基礎知識
    　脳動静脈奇形：NBCA
    　脳動静脈奇形：Onyx
    　【Cutting-edge Knowledge】
    　　　脳動静脈奇形の経静脈的塞栓術：海外の動向と今後の展望
    　脳動静脈奇形：ガンマナイフ治療からの視点
    　【Cutting-edge Knowledge】
    　　　脳動静脈奇形：孤発性AVMの遺伝子変異と内科的治療の可能性
    　頭蓋内硬膜動静脈瘻　　清末一路，ほか
    　【Cutting-edge Knowledge】硬膜動静脈瘻に対する経動脈的塞栓術：
    　　　Onyxの適応拡大
    　【Cutting-edge Knowledge】
    　　　硬 膜動静脈瘻に対するsinus protectionを併用した経動脈的塞栓術
    　【Cutting-edge Knowledge】頭蓋頚椎移行部動静脈瘻：最新の知見
    　脊髄脊椎疾患
    　【Cutting-edge Knowledge】胸 腰椎部の動静脈瘻の鑑別：
    　　　硬膜動静脈瘻と硬膜外動静脈瘻
    　頚動脈狭窄症に対するステント留置術
    　【Technical Tips】C AS中のガイドワイヤー穿孔とトラブルシューティング
    　【Technical Tips】C AS後のin-stent plaque prolapseとその対策
    　【Cutting-edge Knowledge】CASの新たなステント
    　【Cutting-edge Knowledge】頚動脈プラークイメージングupdate
    　【Cutting-edge Knowledge】過灌流症候群予防のためのstaged CASの試み
    　椎骨動脈起始部・鎖骨下動脈狭窄症
    　頭蓋内動脈狭窄症
    　急性脳血管閉塞
    　【Cutting-edge Knowledge】再開通療法の複合治療のバリエーション
    　【Cutting-edge Knowledge】急性期血行再建術におけるAdvanced imaging　
    　脳静脈洞閉塞症
    　脳腫瘍に対する血管内治療
    　外傷性疾患と頭頚部病変
    　【Cutting-edge Knowledge】慢性硬膜下血腫に対する中硬膜動脈塞栓術
    　先天奇形・小児脳神経疾患の脳血管内治療
    　【Cutting-edge Knowledge】血管奇形と血管腫

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 医療倫理とインフォームド・コンセント

P.6 掲載の参考文献
1) 瀧本禎之. 臨床倫理の基礎(2). 臨床倫理学入門II. へるす出版, 東京, 2020.
 
2) 日本医師会 会員の倫理・資質向上委員会. 医師の職業倫理指針[第3版]. 日本医師会, 東京, 2016年.
 
3) 前田正一. インフォームド・コンセント. 入門・医療倫理学I. 赤林朗(編). 勁草書房, 2005.
 
4) 丸祐一. 知りたいのはどんな情報ですか? 診療と研究参加のインフォームド・コンセント. はじめて出会う生命倫理. 玉井真理子, 大谷いづみ(編), 有斐閣, 東京, 2011.
 
5) 田代志門. 臨床倫理. 生命倫理と医療倫理. 金芳堂, 京都, 2014.
 
6) 病院機能評価 機能種別版評価項目一般病院1<3rdG:Ver.2.0>評価の視点/評価の要素:2017年10月1日版
 
7) Elwyn G, Frosch D, et al. Shared decision making:a model for clinical practice. J Gen Intern Med. 2012;27(10):1361-7.
 
8) 河瀬雅紀. 医療者-患者関係. 生命倫理と医療倫理. 金芳堂, 京都, 2014.
 
9) January CT, Wann LS, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76.
 

II 血管解剖 : 治療に必要な血管走行 - 確実に, 正確に理解する -

P.15 掲載の参考文献
1) 小宮山雅樹. 大動脈弓の発生. 脳脊髄血管の機能解剖. メディカ出版, 大阪, 2007, p39-50.
 
2) Faggioli GL, Ferri M, et al. Aortic arch abnormalities are associated with increased risk of neurological events in carotid stent procedures. Eur J Vas Endvasc Surg. 2007;33:436-41.
 
3) Shaw JA, Gravereaux EC, et al. Carotid stenting in the bovine arch. Catheter Cardiovasc Interv. 2003;60:566-9.
PubMed
4) Criado FJ. Mastering Carotid Intervention. Endovascular Today:September, 2003.
 
5) 宝金清博. 内頸動脈血栓内膜剥離術. 脳血行再建術. 中外医学社, 東京, 2000, p117-44.
 
6) 小宮山雅樹. 内頸動脈と椎骨・脳底動脈系の原始血管吻合. 脳脊髄血管の機能解剖. メディカ出版, 大阪, 2007, p51-79.
 
7) Huber P. Extracranial veins. Cerebral angiography. Georg Thieme Verlag, 1982, p183-4.
 
P.49 掲載の参考文献
1) Chen CJ, Chen ST, et al. Hypoplasia of the internal carot id artery with intercavenous anastomosis. Neuroradiology. 1998;40:252-4.
 
2) Parkinson D. Collateral circulation of cavernous carotid artery;anatomy. Can J Surg. 1964;7:251-68.
PubMed
3) Stef fan TN. Vascular anomalies of the middle ear. Laryngoscope. 1968;68:171-91.
 
4) Kelly AB. Tortuousity of the internal carotid artery in relation to the pharynx. J Laryngol Otol. 1925;15-23.
 
5) Padget DH. The Development of the cranial arteries in the human embryo. Contrib Embryol. 1948;32:205-61.
 
6) Pahor AL, Hussain SSM. Persistent stapedial artery. J Laryngol otol. 1992;106:254-7.
 
7) Gray H. Anatomy of the Human Body, Philadelphia, Lea and Febiger, 28th ed, 1966, p596.
 
8) Lie TA. Persistent carotid-basilar and carotid-ver tebral anastomoses. In;Lie TA, ed. Congenital anomalies of the carotid arteries. Amsterdam, The Netherlands:Excerpta Medica Foundation Offices, 1968, p52-94.
 
9) Wollschlaeger G, Wollschlaeger P. The primitive trigeminal artery as seen angiographically and at postmortem examination. Am J Roentgenol Radium Ther Nucl Med. 1964;92:761-2.
PubMed
10) Ohshiro S, Inoue T, et al. Branches of the persistent primitive trigeminal artery? An autopsy case. Neurosurgery. 1993;32:144-7.
PubMed
11) De Caro R, Parenti A, et al. The persistent primitive hypoglossal artery:A rare anatomic variation with frequent clinical implications. Ann Anat. 1995;177:193-8.
PubMed
12) Calzolari F, Ceruti S, et al. Aneurysm of the azygos pericallosal artery. J Neurosurg. 1991;18:277-85.
 
13) Truwit CL. Embriology of the cerebral vasculature. Neuroimag Clin North Am. 1994;4:663-89.
 
14) Perlmutter D, Rhoton AL Jr. Microsurgical anatomy of the distal anterior cerebral artery. 1978;49:204-28.
PubMed
15) Ogawa A, Suzuki M, et al. Vascular anomalies associated with aneurysms of the anterior communicating artery:microsurgical observations. J Neurosurg. 1990;72:706-9.
PubMed
16) San-Galli F, Leman C, et al. Cerebral arterial fenestrations associated with intracranial saccular aneurysms. Neurosurgery. 1992;30:279-83.
PubMed
17) Nozaki K, Taki W, et al. Cerebral aneurysm associated with persistent primitive olfactory artery aneurysm. Acta Neurochir(Wien). 1998;140:397-402.
PubMed
18) Teal JS, Rumbaugh CL, et al. Anomalies of the middle cerebral artery:accessory artery, duplication, and early bifurcation. AJR Am Roentgenol. 1973;118:567-75.
 
19) Komiyama M, Nakajima H, et al. Middle cerebral artery variations:Dulpicated and accessory arteries. AJNR Am J Neuroradiol. 1998;19:45-9.
 
20) Cromton MR. The pathology of ruptured middle cerebral aneurysms with special reference to the differences between the sexes. Lancet. 1962;2:421-5.
 
21) Jain KK. Some observations on the anatomy of the middle cerebral artery. Canad J Surg. 1964;7:134-9.
PubMed
22) Rieger P, Huber G. Fenestration and duplicate origin of the left vertebral artery in angiography:report of three cases. Neuroradiology. 1983;25:45-50.
PubMed
23) San-Galli F, Leman C, et al. Cerebral arterial fenestrations associated with intracranial saccular aneurysms. Neurosurgery. 1992;30:279-83.
PubMed
24) Sanders WP, Sorek PA, et al. Fenestration of intracranial arteries with special attention to associated aneurysms and other anomalies. AJNR Am J Neuroradiol. 1993;14:675-80.
PubMed
25) Tran-Dinh HD. Duplication of the vertebro-basilar system. Aust Radiol. 1991;35:220-4.
 
26) Tasker AD, Byrne J. Basilar artery fenestration in assocciation with aneurysms of the posterior cerebral circulation. Neuroradiology. 1997;39:185-9.
 
27) Black SPW, Ansbacher LE. Saccular aneurysm associated with segmental duplication of the basilar artery. A morphological study. J Neurosurg. 1984;61:1005-8.
 
28) Bouthillier A, van Loveren HR, et al. Segments of the internal carotid artery:a new classification. Neurosurgery. 1996;38:425-33.
PubMed
29) Mizutani K, Toda M, et al. Analysis of the venous channel within the clivus using multidetector computed tomography digital subtraction venography. Neuroradiology. 2017;59:213-9.
PubMed
30) Mizutani K, Akiyama T, et al. Intraosseous venous structures adjacent to the jugular tubercle associated with an anterior condylar dural arteriovenous fistula. Neuroradiology. 2018;60:487-96.
 

III 画像診断 : 撮る, 診る, 読む - 診断を確実に行うために -

P.66 掲載の参考文献
1) Kidwell CS, Alger JR, et al. Beyond mismatch:evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729-35.
PubMed
2) Rohl L, Ostergaard L, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001;32:1140-6.
PubMed
3) Adams HP, Jr., Adams RJ, et al. Guidelines for the early management of patients with ischemic stroke:A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-83.
PubMed
4) Huang IJ, Chen CY, et al. Time course of cerebral infarction in the middle cerebral arterial territory:deep watershed versus territorial subtypes on diffusion-weighted MR images. Radiology. 2001;221:35-42.
PubMed
5) Yamada N, Hayashi K, et al. Time-of-flight MR angiography targeted to coiled intracranial aneurysms is more sensitive to residual flow than is digital subtraction angiography. AJNR Am J Neuroradiol. 2004;25:1154-7.
PubMed
6) Majoie CB, Sprengers ME, et al. MR angiography at 3 T versus digital subtraction angiography in the follow-up of intracranial aneurysms treated with detachable coils. AJNR Am J Neuroradiol. 2005;26:1349-56.
 
7) Takayama K, Taoka T, et al. Usefulness of contrast-enhanced magnetic resonance angiography for follow-up of coil embolization with the enterprise stent for cerebral aneurysms. J Comput Assist Tomogr. 2011;35:568-72.
PubMed
8) Takano N, Suzuki M, et al. Non-Contrast-Enhanced Silent Scan MR Angiography of Intracranial Anterior Circulation Aneurysms Treated with a Low-Profile Visualized Intraluminal Support Device. AJNR Am J Neuroradiol. 2017;38(8):1610-6.
PubMed
9) Oishi H, Fujii T, et al. Usefulness of Silent MR Angiography for Intracranial Aneurysms Treated with a Flow-Diverter Device. AJNR Am J Neuroradio. 2019;40(5):808-14.
 
10) Wada T, Takayama T, et al. Investigation of Safe Termination of Antiplatelet Therapy after LVIS Stent-assisted Cerebral Aneurysm Coiling. JNET. 2019;13(5):199-205. DOI:10.5797/jnet.oa.2018-0112.
 
11) Wycliffe ND, Choe J, et al. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography:a retrospective study. J Magn Reson Imaging. 2004;20:372-7.
PubMed
12) Greer DM, Koroshetz WJ, et al. Magnetic resonance imaging improves detection of intracerebral hemorrhage over computed tomography after intra-arterial thrombolysis. Stroke. 2004;35:491-5.
PubMed
13) Miyasaka T, Taoka T, et al. Application of susceptibility weighted imaging(SWI)for evaluation of draining veins of arteriovenous malformation:utility of magnitude images. Neuroradiology. 2012;54:1221-7.
PubMed
14) Nakagawa I, Taoka T, et al. The use of susceptibility-weighted imaging as an indicator of retrograde leptomeningeal venous drainage and venous congestion with dural arteriovenous fistula:diagnosis and follow-up after treatment. Neurosurgery. 2013;72:47-54;discussion 55.
 
P.73 掲載の参考文献
1) 庄島正明. CFDと脳血管内治療の歴史. 基礎からよくわかる実践的CFD入門. 山本誠(総監修), 根本繁, 高尾洋行(編). メディカ出版, 大阪, 2017, 244-8.
 
2) Japan HeartFlow. https://www.heartflow.com/jp. (Accessed January 3, 2021)
 
3) Geers AJ, Larrabide I, et al. Patient-Specific Computational Hemodynamics of Intracranial Aneurysms from 3D Rotational Angiography and CT Angiography:An In Vivo Reproducibility Study. AJNR Am J Neuroradiol. 2011;32(3):581-6.
 
4) Schneiders JJ, Marquering HA, et al. Intracranial Aneurysm Neck Size Overestimation with 3 D Rotational Angiography:The Impact on Intra-Aneurysmal Hemodynamics Simulated with Computational Fluid Dynamics. AJNR Am J Neuroradiol. 2013;34(1):121-8.
 
5) Skodvin TO, Johnsen L-H, et al. Cerebral Aneurysm Morphology Before and After Rupture:Nationwide Case Series of 29 Aneurysms. Stroke. 2017;48(4):880-6.
PubMed
6) Bjorkman J, Frosen J, et al. Irregular Shape Identifies Ruptured Intracranial Aneurysm in Subarachnoid Hemorrhage Patients With Multiple Aneurysms. Stroke. 2017;48(7):1986-9.
PubMed
7) UCAS Japan Investigators;Morita A, Kirino T, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366(26):2474-82.
 
8) Detmer FJ, Fajardo-Jimenez D, et al. External validation of cerebral aneurysm rupture probability model with data from two patient cohorts. Acta Neurochir(Wien). 2018;160(12):2425-34.
PubMed
9) Kono K, Fujimoto T, et al. Hemodynamic characteristics at the rupture site of cerebral aneurysms:a case study. Neurosurgery. 2012;71(6):E1202-8;discussion 1209.
 
10) Skodvin TO, Evju O, et al. Rupture prediction of intracranial aneurysms:a nationwide matched case-control study of hemodynamics at the time of diagnosis. J Neurosurg. 2018;129(4):854-60.
PubMed
11) Takao H, Murayama Y, et al. Hemodynamic differences between unruptured and ruptured intracranial aneurysms during observation. Stroke. 2012;43(5):1436-9.
PubMed
12) Sugiyama S-I, Niizuma K, et al. Blood Flow Into Basilar Tip Aneurysms:A Predictor for Recanalization After Coil Embolization. Stroke. 2016;47(10):2541-7.
PubMed
13) Caroff J, Mihalea C, et al. A computational fluid dynamics (CFD) study of WEB-treated aneurysms:Can CFD predict WEB "compression" during follow-up? J Neuroradiol. 2017;44(4):262-8.
PubMed
14) Fujimura S, Shojima M, et al. Numerical simulation techniques to predict aneurysm recanalization after coil embolization and their problems. Journal of Biorheology. 2019;33(2):32-42. https://www.jstage.jst.go.jp/article/jbr/33/2/33_32/_article/-char/en. (Accessed June 23, 2020)
 
15) Becske T, Brinjikji W, et al. Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms:Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery. 2017;80(1):40-8.
 
16) Paliwal N, Jaiswal P, et al. Outcome prediction of intracranial aneurysm treatment by flow diverters using machine learning. Neurosurg Focus. 2018;45(5):E7.
PubMed
17) Zhang M, Tupin S, et al. Implementation of computer simulation to assess flow diversion treatment outcomes:systematic review and meta-analysis. J Neurointerv Surg. Published online October 23, 2020.
 
18) Oishi H, Teranishi K, et al. Flow Diverter Therapy Using a Pipeline Embolization Device for 100 Unruptured Large and Giant Internal Carotid Artery Aneurysms in a Single Center in a Japanese Population. Neurol Med Chir(Tokyo). 2018;58(11):461-7.
 
19) Sweid A, Starke RM, et al. Predictors of Complications, Functional Outcome, and Morbidity in a Large Cohort Treated With Flow Diversion. Neurosurgery. 2020;87(4):730-43.
 
20) Li W, Tian Z, et al. Hemodynamic Analysis of Postoperative Rupture of Unruptured Intracranial Aneurysms after Placement of Flow-Diverting Stents:A Matched Case-Control Study. AJNR Am J Neuroradiol. 2019;40(11):1916-23.
PubMed
P.89 掲載の参考文献
1) 日本超音波医学会用語・診断基準委員会. 超音波による頸動脈病変の標準的評価法 2017. https://wwwjsumorjp/committee/diagnostic/pdf/jsum0515_guidelinepdf 2017.
 
2) Lorenz MW, Markus HS, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness:a systematic review and meta-analysis. Circulation. 2007;115(4):459-67.
PubMed
3) 山上宏. 頸動脈アテローム性動脈硬化病変:Bモード, integrated backscatterとプラーク性状. 日本脳神経超音波学会(編). 脳神経超音波マニュアル. 2006.
 
4) Gronholdt ML, Nordestgaard BG, et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation. 2001;104(1):68-73.
PubMed
5) Biasi GM, Froio A, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting:the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004;110(6):756-62.
PubMed
6) Gupta A, Kesavabhotla K, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis:a systematic review and meta-analysis. Stroke. 2015;46(1):91-7.
PubMed
7) Coli S, Magnoni M, et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries:correlation with histology and plaque echogenicity. J Am Coll Cardiol. 2008;52(3):223-30.
PubMed
8) Xiong L, Deng YB, et al. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology. 2009;251(2):583-9.
PubMed
9) Grant EG, Benson CB, et al. Carotid artery stenosis:gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229(2):340-6.
PubMed
10) Jahromi AS, Cina CS, et al. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis:a systematic review and meta-analysis. J Vasc Surg. 2005;41(6):962-72.
PubMed
11) 日本脳神経超音波学会. 頸部血管超音波ガイドライン. Neurosonology. 2006;19(2):49-69.
 
12) Saito K, Kimura K, et al. Vertebral artery occlusion in duplex color-coded ultrasonography. Stroke. 2004;35(5):1068-72.
PubMed
13) Setacci C, Chisci E, et al. Grading carotid intrastent restenosis:a 6-year follow-up study. Stroke. 2008;39(4):1189-96.
PubMed
14) Lal BK, Hobson RW, et al. Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg. 2008;47(1):63-73.
PubMed
15) Nederkoorn PJ, Brown MM. Optimal cut-off criteria for duplex ultrasound for the diagnosis of restenosis in stented carotid arteries:review and protocol for a diagnostic study. BMC Neurol. 2009;9:36.
PubMed
16) Ogata T, Kimura K, et al. Diagnosis of middle cerebral artery occlusive lesions with contrast-enhanced transcranial color-coded real-time sonography in acute stroke. Neuroradiology. 2005;47(4):256-62.
PubMed
17) 日本脳神経超音波学会. 頭蓋内超音波検査ガイドライン. Neurosonology. 2006;19(3):113-31.
Medical*Online
18) Jansen C, Sprengers AM, et al. Prediction of intracerebral haemorrhage after carotid endarterectomy by clinical criteria and intraoperative transcranial Doppler monitoring. Eur J Vasc Surg. 1994;8(3):303-8.
PubMed
19) Ackerstaff RG, Moons KG, et al. Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke. 2000;31(8):1817-23.
PubMed
20) Dalman JE, Beenakkers IC, et al. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg. 1999;18(3):222-7.
PubMed
21) Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke. 1999;30(7):1440-3.
PubMed
22) Verhoeven BA, de Vries JP, et al. Carotid atherosclerotic plaque characteristics are associated with microembolization during carotid endarterectomy and procedural outcome. Stroke. 2005;36(8):1735-40.
PubMed
23) Ackerstaff RG, Suttorp MJ, et al. Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting. J Vasc Surg. 2005;41(4):618-24.
PubMed
24) Montorsi P, Caputi L, et al. Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery Stenting. JACC Cardiovasc Interv. 2020;13(4):403-14.
PubMed
25) Vos JA, van den Berg JC, et al. Carotid angioplasty and stent placement:comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology. 2005;234(2):493-9.
PubMed
26) 山上宏. 虚血性脳卒中:診断と治療の進歩II. 診断2. 超音波診断. 日内会誌. 2009;98(6):1240-8.
 
27) 山上宏. 頸動脈病変の評価 超音波. エキスパートから学ぶCAS実践マニュアル. 伊刈祐二, 坂井信幸(編), 南江堂, 東京, 2009, p53-9.
 
P.103 掲載の参考文献
1) 橋川一雄. 最新脳SPECT/PETの臨床. 脳血流SPECTの検査法. メジカルビュー社, 東京, 2006, p46-62.
 
2) Minoshima S, Frey KA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18 -FDG PET. J Nucl Med. 1995;36:1238-48.
 
3) Friston KJ, Frith CD, et al. Comparing functional(PET) images:the assessment of significant change. J Cereb Blood Flow Metab. 1991;11:690-9.
 
4) Matsuda H, Mizumura S, et al. Conversion of brain SPECT images between different collimators and reconstruction processes for analysis using statistical parametric mapping. Nucl Med Commun. 2004;25:67-74.
PubMed
5) Mizumura S, Kumita S, et al. Development of quantitative analysis method for stereotactic brain image:assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med. 2003;17:289-95.
PubMed
6) JET study group:Japanese EC-IC Bypass Trial (JET study) 中間解析結果(第二報). 脳卒中の外科. 2002;30:434-7.
 
7) Sundt TM Jr, Houser OW, et al. Carotid endarterectomy:results, complications, and monitoring techniques. Adv Neurol. 1977;16:97-119.
PubMed
8) Moulakakis KG, Mylonas SN, et al. Hyperperfusion syndrome after carotid revascularization. J Vasc Surg. 2009;49:1060-8.
PubMed
9) 小笠原邦昭. 過灌流(Hyperperfusion). 滝和郎(編集). 頸動脈ステント留置術ハンドブック. 診断と治療社, 東京, 2009, p102-6.
 
10) Hosoda K, Kawaguchi T, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke. 2001;32:1567-73.
PubMed
11) Hosoda K, Kawaguchi T, et al. Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke. 2003;34:1187-93.
PubMed
12) Komoribayashi N, Ogasawara K, et al. Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab. 2006;26:878-84.
PubMed
13) Ogasawara K, Sakai N, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting:retrospective review of 4494 patients. J Neurosurg. 2007;107:1130-6.
PubMed
14) Abou-Chebl A, Reginelli J, et al. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007;69:690-6.
PubMed
15) Ogasawara K, Inoue T, et al. Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery. 2004;55:1060-7.
PubMed
16) Barber PA, Demchuk AM, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-4.
 
17) Ueda T, Sakaki S, et al. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2360-5.
PubMed
18) Ogasawara K, Ogawa A, et al. Brain single-photon emission CT studies using 99 mTc-HMPAO and 99 mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion. AJNR Am J Neuroradiol. 2001;22:48-53.
 
19) Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome:a meta-analysis. Stroke. 2007;38:967-73.
PubMed
20) Tomura N, Omachi K, et al. Comparison of technetium Tc99 m hexamethylpropyleneamine oxime single-photon emission tomograph with stump pressure during the balloon occlusion test of the internal carotid artery. AJNR Am J Neuroradiol. 2005;26:1937-42.
 
21) 金森勇雄, 福山誠介, 他. PET. 実践核医学検査. 医療科学社, 東京, 2009, p215-26.
 

IV 脳血管内治療 : 機器・管理編 - 操作を行う前に -

P.120 掲載の参考文献
1) Yadav JS, Wholey MH, et al. Protected Carotid-Artery Stenting versus Endarterectmy in High-Risk Patient. N Engl J Med. 2004;351:1493-501.
 
2) Katayama H, Yamaguchi K, et al. Adverse reaction to ionic and nonionic contrast media. A report from the Japanese Committee in the Safety of Contrast Media. Radiology. 1990;175:621-8.
PubMed
3) Mueller C, Buerkle G, et al. Prevention of contrast media-associated nephropathy. Arch Intern Med. 2002;162:329-36.
PubMed
4) Aspelin P, Aubry P, et al. Nephrotic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-9.
 
5) 2020年JCSガイドラインフォーカスアップデート版 冠動脈疾患患者における抗血栓療法. 2020年3月13日発行.
 
6) Urban P, Mehran R, et al. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention. A Consensus Document From the Academic Research Consortium for High Bleeding Risk. Circulation. 2019;140:240-61.
 
7) Urban P, Mehran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention:a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019;40:2632-53.
 
8) Tantry US, Bonello L, et al. Working Group on On-Treatment Platelet Reactivity:Concensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261-73.
 
9) Stone GW, Witzenbichler B, et al. ADAPT-DES Investigators:Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES):a prospective multicentre registry study. Lancet. 2013;382:614-23.
PubMed
10) Cannon CP, Bhatt DL, et al. RE-DUAL PCI Steering Committee and Investigators. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2017;377:1513-24.
 
11) Gibson CM, Mehran R, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016;375:2423-34.
PubMed
12) Lopes RD, Heizer G, et al. AUGUSTUS Investigators. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019;380:1509-24.
PubMed
13) Vranckx P, Valgimigli M, et al. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation(ENTRUST-AF PCI):a randomised, open-label, phase 3b trial. Lancet. 2019;394:1335-43.
PubMed
14) Lopes RD, Hong H, et al. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention:A Network Meta-analysis of Randomized Controlled Trials. JAMA Cardiol. 2019;4:747-55.
PubMed
15) Steffel J, Verhamme P, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330-93.
PubMed
16) Nonaka T, Oka S, et al. Prediction of prolonged postprocedual hypotention after carotid artery stenting. Neurosurgery. 2005;57:472-7.
 
17) Ogasawara K, Sakai N, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting:retrospective review of 4494 patients. J Neurosurg. 2007;107:1130-6.
PubMed
18) 小笠原邦昭, 小川彰. 頸部頸動脈内膜剥離術後過還流:その臨床的意義, 発生メカニズム, ステント後過還流との相違. 分子心血管病. 2007;8:22-7.
 
19) 小笠原邦昭. 頸動脈ステント留置術(CAS)後過還流. 医学のあゆみ. 2009;228:839-42.
 
20) 中原一郎, 渡邊芳彦, 他. 頸動脈ステント留置術に続発したコレステロール塞栓症の1例. Jpn J Neurosurg (Tokyo). 2004;13:583-7.
 
21) Fukumoto Y, Tsutsui H, et al. The incidence and risk factors cholesterol embolization syndrome, a complication of cardiac catheterization:a prospective study. J Am Coll Cardiol. 2003;42:211-6.
PubMed
22) 伊藤建二, 兼岡秀俊, 他. 心血管手術後に異なる時間経過で死亡したコレステロール塞栓症の3剖検例. J Jpn Coll Angiol. 2008;48:75-80.
 
23) Enomae M, Takeda S, et al. Chronic cholesterol cr ystal embolism with a spontaneous onset. Intern Med. 2007;46:1123-6.
 
24) 大西泰彦. コレステロール結晶塞栓症の皮膚症状. Visual Dermatology. 2002;1:1006-8.
 
25) 大西泰彦. コレステロール結晶塞栓症(Cholesterol Crystal Embolism:CCE)の臨床・病理学的検討;皮膚病理所見の推移と早期診断における皮膚生検の重要性について. 東邦医会誌. 2001;48:435-43.
 
26) Machino-Ohtsuka T, Seo Y, et al. Combined assesment of carotid vulnerable plaque, renal insufficiency, eosinophilia, and hs-CRP for predicting risk aortic plaque of cholesterol crystal embolism. Circ J. 2010;74:51-8.
 
27) Saito T. Corticosteroid pulse the therapy for the treatment of cholesterol embolic disease. Intern Med. 2003;42:1159-60.
PubMed
28) Motegi S, Abe M, et al. Cholesterol crystal embolization:skin manifestation, gastrointestinal and central nervous symptom treated with corticosteroid. J Dermatol. 2005;32:295-8.
PubMed
29) Sanai T, Matsui R, et al. LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery:a case report. Angiology. 2006;57:379-82.
PubMed
30) 厚生労働省. 重篤副作用疾患別対応マニュアル ヘパリン起因性血小板減少症(HIT).
 
31) 松尾武文. ヘパリン起因性血小板減少症(Heparin-induced thrombocytopenia:HIT)の診断. 止血血栓誌. 2008;19:191-4.
 
32) 和中敬子, 岡本歌子. ヘパリン起因性血小板減少症の診断と治療. 臨床麻酔. 2009;33:1597-604.
 
33) 宮田茂樹. ヘパリン起因性血小板減少症. 臨床血液. 2012;53:1709-19.
 
34) 宮田茂樹. ヘパリン起因性血小板減少症における最新の知見. 血栓止血誌. 2012;23:362-74.
 
35) Watson H, Davidson S, et al. Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia:second edition. Br J Haematol. 2012;159:528-40.
PubMed
36) Linkins LA, Dans AL, et al. American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia:Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012:141:e495 S-530 S.
 
37) Warkentin TE, Greinacher A, eds. Heparin- induced Thrombocytopenia. Fifth edition, New York, Informa Healthcare, 2012.
 
38) 血栓止血研究プロジェクトHIT情報発信. [ホームページ www.hit-center.jp]
 
39) 滝和郎(編). 頸動脈ステント留置術ハンドブック. 診断と治療社, 東京, 2009.
 
40) 滝和郎, 寺田友昭, 他(編). 合併症例から学ぶ脳神経血管内治療. メディカ出版, 大阪, 2009.
 
41) 寺田友昭(編). これから始める人のための頸動脈ステント留置術. 中山書店, 東京, 2008.
 
42) 大石英則(編). 脳動脈瘤に対する血管内治療 知行合一. メジカルビュー社, 東京, 2017.
 
43) 坂井信之, 江面正幸, 他(編). 脳血管内治療の進歩ブラッシュアップセミナー2018. 診断と治療社, 東京, 2019.
 
P.125 掲載の参考文献
1) Leon MB, Baim DS, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665-71.
 
2) American College of Cardiology Foundation;American Society of Interventional & Therapeutic Neuroradiology;Society for Cardiovascular Angiography and Interventions;Society for Vascular Medicine and Biology;Society of Interventional Radiology, Bates ER, Babb JD, Casey DE Jr, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol. 2007;49:126-70.
 
3) 日本脳神経外科学会, 日本脳卒中学会, 日本脳神経血管内治療学会承認:頭蓋内動脈ステント(脳動脈瘤治療用 Flow Diverter)適正使用指針 第3版.
 
4) Coukell AJ, Markham A. Clopidogrel. Drugs. 1997;54:745-50.
PubMed
5) Matetzky S, Shenkman B, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-5.
PubMed
6) Mega JL, Close SL, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354-62.
PubMed
7) Holmes MV, Perel P, et al. CYP2 C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events:a systematic review and meta-analysis. JAMA. 2011;306:2704-14.
 
8) Stone GW, Witzenbichler B, et al. ADAPT-DES Investigators. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents(ADAPTDES):a prospective multicentre registry study. Lancet. 2013 ;382:614-23.
PubMed
9) Kang HS, Kwon BJ, et al. Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms:clinical implications. AJNR Am J Neuroradiol. 2010;31:1206-10.
PubMed
10) Delgado Almandoz JE, Kadkhodayan Y, et al. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg. 2014;6(10):767-73.
PubMed
11) Kubota T, Chiba K, et al. Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population. Clin Pharmacol Ther. 1996;60:661-6.
 
12) 久保田隆廣, 千葉寛, 伊賀立二. CYP2C19, CYP2D6, およびCYP2C9の遺伝子多型と人種差. 薬物動態. 2001;16:69-74.
Medical*Online
13) Kang HS, Kwon BJ, et al. Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms:clinical implications. AJNR Am J Neuroradiol. 2010;31:1206-10.
PubMed
14) Delgado Almandoz JE, et al. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg. 2014;6(10):767-73.
PubMed
15) Nishi H, Nakahara I, et al. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J Neurointerv Surg. 2016;8:949-53.
PubMed
16) Wiviott SD, Braunwald E, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-15.
PubMed
17) Higashiguchi S, Sadato A, et al. Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel. J Neurointerv Surg. 2021. Epub ahead of print. PMID:33632886.
 
18) Pan Y, Elm JJ, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack:A pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and platelet-oriented inhibition in new tia and minor ischemic stroke (POINT) trials. JAMA Neurol. 2019;76:1466-73.
PubMed
19) Toyoda K, Yasaka M, et al. Bleeding with Antithrombotic Therapy(BAT)Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease:a prospective, multicenter, observational study. Stroke. 2008;39:1740-5.
 
20) 木村一雄, 中村正人(班長). 2020年JCSガイドラインフォーカスアップデート版, 冠動脈疾患患者における抗血栓療法. https://www.j-circ.or.jp/guideline/guidelineseries/
 
P.140 掲載の参考文献
1) Tanoue S, Kiyosue H, et al. Three dimensional reconstructed image after rotational angiography in the evaluation of intracranial aneurysms:surgical correlation. Neurosurgery. 2003;47:866-71.
 
2) Abe T, Hirohata M, et al. Clinical benefits of rotational 3 D angiography in endovascular treatment of ruptured cerebral aneurysm. AJNR Am J Neuroradiol. 2002;23:686-8.
 
3) Schueler BA, Kallmes DF, et al. 3 D cerebral angiography:Radiation dose comparison with digital subtruaction angiography. AJNR Am J Neuroradiol. 2005;26:1898-901.
 
4) 谷川仁, 他. 脳動脈瘤塞栓術における3D-DSA使用に伴う放射線被曝線量の低減効果について. 臨放. 2002;47:1559-64.
 
5) Soderman M, Babic D, et al. 3 D roadmap in neurogangiography:technique and clinical interest. Neuroradiology. 2005;47:735-40.
 
6) Jou L-D, Mohamed A, et al. 3 D Rotational Digital Subtraction Angiography May Underestimate Intracranial Aneurysms:Findings from Two Basilar Aneurysms. AJNR Am J Neuroradiol. 2007;28:1690-2.
 
7) 谷川仁, 他. 3D-DSAにおける疑似狭窄アーチファクトの研究. 日放技学誌. 2002;58:1687-95.
 
8) Hirai T, Korogi Y, et al. Pseudostenosis phenomenon at volume-rendered three dimensional digital angiography of intracranial arteries:frequency, location and effect on image evaluation. Radiology. 2004;232:882-7.
PubMed
9) Katada K. Multislice CT-neuroradiological applications. Brain Nerve. 2007;59:451-7.
PubMed
10) ICRP ref 4825 -3093 -1464 Statement on Tissue Reaction. Approved by the Commission on April 21, 2011.
 
11) 公益社団法人 日本医学放射線学会, 特定非営利活動法人 日本脳神経血管内治療学会, 他. 医療スタッフの放射線安全に係るガイドライン-水晶体の被ばく管理を中心に-. 京都医療科学大学, 京都, 2020年.
 
12) 日本アイソトープ協会(訳). ICRP Publication 85. IVRにおける放射線障害の回避. 丸善. 東京, 2003.
 
13) 医療被曝研究情報ネットワーク(J-RIME). 日本の診断参考レベル(2020年版). http://www.radher.jp/J-RIME/report/JapanDRL2020_jp.pdf
 
14) Abe T, Furui S, et al. Quantitative evaluation of light scattering intensities of the crystalline lens for radiation related minimal change in interventional radiologists:a cross-sectional pilot study. J Radiat Res. 2013;54(2):315-21.
PubMed
P.157 掲載の参考文献
1) Iihara K, Satow T, et al. Hybrid operating room for the treatment of complex neurovascular and brachiocephalic lesions. J Stroke Cerebrovasc Dis. 2013;22:e277-85.
PubMed
2) Leng LZ, Rubin DG, et al. Fusion of intraoperative three-dimensional rotational angiography and flat-panel detector computed tomography for cerebrovascular neuronavigation. World Neurosurg. 2013;79:504-9.
PubMed
3) Kotowski M, Sarrafzadeh A, et al. Intraoperative angiography reloaded:a new hybrid operating theater for combined endovascular and surgical treatment of cerebral arteriovenous malformations:a pilot study on 25 patients. Acta Neurochir(Wien). 2013;155:2071-78.
PubMed
4) Fandino J, Taussky P, et al. The concept of a hybrid operating room:applications in cerebrovascular surgery. Acta Neurochir Suppl. 2013;115:113-7.
PubMed
5) Yamakawa K, Kiyama S, et al. Incidence and neurological outcomes of aneurysm rupture during interventional neuroradiology procedures in a hybrid operating suite. J Anesth. 2012;26:592-4.
 
6) Murayama Y, Irie K, et al. Robotic digital subtraction angiography systems within the hybrid operating room. Neurosurgery. 2011;68:1427-32.
PubMed

V 脳血管内治療 : 手技編 - 基本手技はマスターしているか ? -

P.173 掲載の参考文献
1) Hayashi K, Horie N, et al. Quadruple coaxial catheter system on transvenous embolization for dural arteriovenous fistula. Neurol Res. 2015;37:328-31.
PubMed
2) 林健太郎, 森川実, 他. 頸動脈ステント留置術でデバイスを用いた穿刺部止血後に総大腿動脈閉塞を来した1例. Brain Nerve. 2010;62:173-6.
 
P.178 掲載の参考文献
1) Kiemeneij F. Left distal transradial access in the anatomical snuffbox for coronary angiography (ldTRA)and interventions(ldTRI). EuroIntervention. 2017;13:851-7.
PubMed
2) Sgueglia GA, Di Giorgio A, et al. Anatomic basis and physiological rationale of distal radial artery access for percutaneous coronary and endovascular procedures. JACC Cardiovasc Interv. 2018;11:2113-9.
PubMed
3) Aoi S, Hyun WW, et al. Distal transradial artery access in the anatomical snuffbox for coronary angiography as an alternative access site for faster hemostasis. Catheter Cardiovasc Interv. 2019;94:651-7.
 
4) Kim Y, Ahn Y, et al. Gender differences in the distal radial artery diameter for the snuffbox approach. Cardiol J. 2018;25:639-41.
PubMed
5) Soydan E, Mustafa A. Coronary angiography using the left distal radial approach-an alternative site to conventional radial coronary angiography. Anatol J Cardiol. 2018;19:243-8.
 
6) Kinkori T, Watanabe K. Left distal radial approach for stent assisted coiling of left vertebral artery aneurysm. JNET. 2019;13:275-9.
 
7) Trimarch S, Smith DE, et al. Retrospective hematoma after percutaneous coronary intervention:prevalence, risk factors, management, outcomes, and predictors of mortality:a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium)registry. JACC Cardiovasc Interv. 2010;3:845-50.
 
8) Pua U, Sim JZT, et al. Feasiblity study of "snuff box" radial access for visceral interventions. J Vasc Interv Radiola. 2018;29:1276-80.
 
9) Lee DG, Lee DH, et al. Feasibility of the transbrachial approach in various neurointerventional procedures. Neurointervention. 2015;10:74-81.
PubMed
10) Hadjivassiliou A, Kiemeneij F, et al. Ultrasound-guided access of the distal radial artery at the anatomical snuffbox for catheter-based vascular interventions:a technical guide. EuroIntervention. 2021;16:1342-8.
 
P.183 掲載の参考文献
1) Das R, Ahmed K, et al. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures:a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2011;34:723-38.
PubMed
2) Frank JJ, Kamalakannan D, et al. Retroperitoneal hematoma in patients undergoing cardiac catheterization. J Intervent Cardiol. 2010;23:569-74.
PubMed
3) Gehling G, Ludwig J, et al. Percutaneous occlusion of femoral artery pseudoaneurysm by para-aneurysmal saline injection. Catheter Cardiovasc Interv. 2003;58:500-4.
PubMed
4) Liau C-S, Ho F-M, et al. Treatment of iatrogenic femoral artery pseudoaneurysm with percutaneous thrombin injection. J Vasc Surg. 1997;26:18-23.
PubMed
5) Shigematsu T, Fujinaka T, et al. Endovascular therapy for asymptomatic unruptured intracranial aneurysms:JR-NET and JR-NET2 findings. Stroke. 2013;44:2735-42.
PubMed
P.209 掲載の参考文献
1) Marks MP, Chee H, et al. A mechanically detachable coil for the treatment of aneurysms and occlusion of blood vessels. AJNR Am J Neuroradiol. 1994;15:821-7.
PubMed
2) Guglielmi G, Vinuela F, et al. Electrothrombosis of saccular aneurysms via endovascular approach. Part 2:Preliminary clinical experience. J Neurosurg. 1991;77:8-14.
 
3) Hirsch JA, Bendok BR, et al. Midterm clinical experience with a complex-shaped detachable platinum coil system for the treatment of cerebral aneurysms:Trufill DCS Orbit detachable coil system registry interim results. J Vasc Interv Radiol. 2007;18:1487-9.
PubMed
4) Pierot L, Flandroy P, et al. Selective endovascular treatment of intracranial aneurysms using micrus microcoils:preliminary results in a series of 78 patients. J Neuroradiol. 2002;29:114-21.
 
5) Cloft HJ, Kallmes DF. Aneurysm packing with HydroCoil Embolic System versus platinum coils:initial clinical experience. AJNR Am J Neuroradiol. 25;2004:60-2.
PubMed
6) Sadato A, Taki W, et al. Immediately detachable coil for aneurysm treatment. AJNR Am J Neuroradiol. 1995;16:1459-62.
PubMed
7) Veznedaroglu E, Koebbe CJ, et al. Initial experience with bioactive cerecyte detachable coils:impact on reducing recurrence rates. Neurosurgery. 2008;62:799-805.
PubMed
8) Linfante I, Deleo MJ, et al. Cerecyte versus Platinum coil in the treatment of intracranial aneurysms:Packing attenuation and clinical and angiographic midterm result. AJNR Am J Neuroradiol. 2009;30:1496-501.
 
9) Geyik S, Ertugrul O, et al. Comparison of bioactive coils and bare platinum coils for treatment of intracranial aneurysms:a matched-pair analysis. J Neurosurg. 2010;112:709-13.
PubMed
10) White PM, Lewis SC, et al. HydroCoil Endovascular Aneurysm Occlusion and Packing Study(HELPS Trial):Procedual Safety and Operetor-Assesed Efficacy Result. AJNR Am J Neuroradiol. 2008;29:217-23.
 
11) Wakhloo AK, Lanzino G, et al. Stents for intracranial aneurysms:the beginning of a new endovascular era? Neurosurgery. 1998;43(2):377-9.
PubMed
12) Sheth SA, Patel NS, et al. Treatment of wide-necked basilar tip aneu-rysm not amenable to Y-stenting using the PulseRider device. J Neurointerv Surg. 2016;8:e37.
 
13) Arthur AS, Molyneux A, et al. The safety and effectiveness of the Woven EndoBridge(WEB)system for the treatment of wide-necked bifurcation aneurysms:final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study. J Neurointerv Surg. 2019;11:924-30.
PubMed
14) Sluzewski M, van Rooij WJ, et al. Relation between aneurysm volume, packing, and compaction in 145 cerebral aneurysms treated with coils. Radiology. 2004;231:653-8.
PubMed
15) Yagi K, Satoh K, et al. Evaluation of aneurysm stability after endovascular embolization with Guglielmi detachable coils:correlation between long-term stability and volume embolization ratio. Neurol Med Chir(Tokyo). 2005;45(11):561-5.
PubMed
16) Murayama Y, Nien YL, et al. Guglielmi detachable coil embolization of cerebral aneurysms:11 year's experience. J Neurosurg. 2003;98:959-66.
 
17) 中澤和智, 太田剛史, 他. コイル特性と考慮した脳動脈瘤瘤内塞栓-そのコンセプトと実験的データより-. 第22回日本脳神経血管内治療学会総会講演集:11-6, 2006.
 
18) 中澤和智, 村尾健一. 脳動脈瘤塞栓術の理論と実際. 脳外速報, 2008;18:992-1000.
Medical*Online
19) Slob MJ, van Rooij WJ, et al. Influence of coil thickness on packing, re-opening and retreatment of intracranial aneurysms:a comparative study between two types of coils. Neurol Res. 2005;27(Suppl1):S116-S119.
 
20) Byun HS, Rhee K. CFD modeling of blood flow following coil embolization of aneurysms. Med Eng Phys. 2004;26(9):755-61.
PubMed
21) 佐藤徹, 村尾健一, 他. 解剖に基づく海綿静脈洞部硬膜動静脈瘻の血管内治療. 脳外誌. 17;2008:679-89.
 
22) 小宮山雅樹. 頭頚部腫瘍・頭蓋内腫瘍の塞栓術と動注化学療法. 症例から学ぶ脳血管内治療改訂2版, メディカ出版, 大阪, 2004, p301-14.
 
23) Sluzewski M, van Rooij WJ, et al. Embolization of meningiomas:comparison of safety between calibrated microspheres and polyvinyl-alcohol particles as embolic agents. Am J Neuroradiol. 2013;34(4):727-9.
PubMed
24) Kim LJ, Albuquerque FC, et al. Low morbidity associated with use of n-butyl cyanoacrylate liquid adhesive for preoperative transarterial embolization of central nervous system tumors. Neurosurgery. 2006;59:98-104.
 
P.212 掲載の参考文献
1) Molyneux A, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms:a randomised trial. Lancet. 2002;360:1267-74.
PubMed
2) Murayama Y, et al. Guglielmi detachable coil embolization of cerebral aneurysms:11 years' experience. J Neurosurg. 2003;98:959-66.
PubMed
3) Ng P, et al. Endovascular treatment of intracranial aneurysms with Guglielmi detachable coils:analysis of midterm angiographic and clinical outcomes. Stroke. 2002;33:210-7.
PubMed
4) Gonzalez N, et al. Treatment of unruptured aneurysms with GDCs:clinical experience with 247 aneurysms. AJNR Am J Neuroradiol. 2004;25:577-83.
PubMed
5) Gallas S, et al. A multicenter study of 705 ruptured intracranial aneurysms treated with Guglielmi detachable coils. AJNR Am J Neuroradiol. 2005;26:1723-31.
PubMed
6) Raymond J, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003;34:1398-403.
PubMed
7) Cloft HJ. Hydrocoil for Endovascular Aneurysm Occlusion(HEAL)study:3-6 month angiographic follow-up results. AJNR Am J Neuroradiol. 2007;28:152-4.
PubMed
8) Gunnarsson T, et al. Angiographic and clinical outcomes in 200 consective patients with cerebral aneurysm treated with Hydrogel-coated coils. AJNR Am J Neuroradiol. 2009;30:1657-64.
 
9) White PM, et al. Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS):a randomised controlled troal. Lancet Oncol. 2011;12:997-1003.
 
10) Park JH, et al. Embolization of intracranial aneurysms with Hydrosoft coils:Results of the Korean Multicenter Study. AJNR Am J Neuroradiol. 2011;32:1756-61.
PubMed
11) Ishii A, et al. Immediate and midterm outcomes of patients with cerebral aneurysms treated with Matrix1 and Matrix2 coils:a comparative analysis based on a single-center experience in 250 consective cases. Neurosurgery. 2008;63:1071-7;discussion 1077-9.
 
12) McDougall CG, et al. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms:The MAPS(Matrix and Platinum Science)trial. AJNR Am J Neuroradiol. 2014;35:935-42.
PubMed
13) D'Agostino SJ, et al. Clinical experience with Matrix2 360 degrees coils in the treatment of 100 intracranial neurysms. Surg Neurol. 2009;72:41-7.
 
14) Bendszus M, et al. Endovascular occlusion of aneurysms using a new bioactive coil:a matched pair analysis with bare platinum coils. Stroke. 2007;38:2855-7.
 
15) Veznedaroglu E, et al. Initial experience with bioactive cerecyte detachable coils:impact on reducing recurrence rates. Neurosurgery. 2008;60:799-805;discussion 805-6.
 
16) Linfante I, et al. Cerecyte versus platinum coils in the treatment of intracranial aneurysms:packing attenuation and clinical and angiographic midterm results. AJNR Am J Neuroradiol. 2009;30:1496-501.
PubMed
17) Molyneux AJ, et al. Cerecyte coil trial:angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012;43:2544-50.
PubMed
18) Coley S, et al. Cerecyte coil trial:procedural safety and clinical outcomes in patients with ruptured and unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2012;33:474-80.
PubMed
19) Raymond J, et al. Patient prone to Recurrence after Endovascular Treatment:Periprocedural Results of the PRET Randomized Trial on Large and Recurrent Aneurysms. AJNR Am J Neuroradiol. 2014;35:1667-76.
PubMed
20) Taschner CA, et al. Second-Generation Hydrogel Coils for the Endovascular Treatment of Intracranial Aneurysms. A Randomized Controlled Trial. Stroke. 2018;49:667-74.
PubMed
21) Imamura H, et al. Prospective Registry of Embolization of Intracranial Aneurysms Using HydroSoft Coils:Results of the Japanese HydroSoft Registry. World Neurosurg. 2019;127:E631-E37
 
22) Bernard RB, et al. The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT):A Randomized Controlled Trial of the Second-Generation Hydrogel Coil. Neurosurgery. 2020;86:615-24.
 
P.216 掲載の参考文献
1) Abdalkader M, Piotin M, et al. Coil migration during or after endovascular coiling of cerebral aneurysms. J Neurointerv Surg. 2020;12:505-11.
PubMed
2) Turek G, Kochanowicz J, et al. Early surgical removal of migrated coil/stent after failed embolization of intracranial aneurysm. J Neurosurg. 2015;123:841-7.
PubMed
P.231 掲載の参考文献
1) Lanzino G, Wakhloo AK, et al. Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg. 1999;91(4):538-46.
PubMed
2) Fiorella D, Albuquerque FC, et al. In-stent stenosis as a delayed complication of neuroform stent-supported coil embolization of an incidental carotid terminus aneurysm. AJNR Am J Neuroradiol. 2004;25(10):1764-7.
PubMed
3) Fiorella D, Albuquerque FC, et al. Usefulness of the Neuroform stent for the treatment of cerebral aneurysms:results at initial (3-6-mo) follow-up. Neurosurgery. 2005;56(6):1191-201;discussion 1201-2.
 
4) Lessne ML, Shah P, et al. Thromboembolic complications after Neuroform stent-assisted treatment of cerebral aneurysms:the Duke Cerebrovascular Center experience in 235 patients with 274 stents. Neurosurgery. 2011;69(2):369-75.
PubMed
5) Higashida RT, Halbach VV, et al. Initial clinical experience with a new self-expanding nitinol stent for the treatment of intracranial cerebral aneurysms:the Cordis Enterprise stent. AJNR Am J Neuroradiol. 2005;26(7):1751-6.
PubMed
6) Mocco J, Snyder KV, et al. Treatment of intracranial aneurysms with the Enterprise stent:a multicenter registry. J Neurosurg, 2009;110(1):35-9.
 
7) Mocco J, Fargen KM, et al. Delayed thrombosis or stenosis following enterprise-assisted stent-coiling:is it safe? Midterm results of the interstate collaboration of enterprise stent coiling. Neurosurgery. 2011;69(4):908-13;discussion 913-4.
 
8) Kis B, Weber W, et al. Elective treatment of saccular and broad-necked intracranial aneurysms using a closed-cell nitinol stent (Leo). Neurosurgery. 2006;58(3):443-50;discussion 443-50.
 
9) Yavuz K, Geyik S, et al. Immediate and midterm follow-up results of using an electrodetachable, fully retrievable SOLO stent system in the endovascular coil occlusion of wide-necked cerebral aneurysms. J Neurosurg. 2007;107(1):49-55.
PubMed
10) Klisch J, Clajus C, et al. Coil embolization of anterior circulation aneurysms supported by the Solitaire AB Neurovascular Remodeling Device. Neuroradiology. 2010;52(5):349-59.
PubMed
11) Piotin M, Blanc R, et al. Stent-assisted coiling of intracranial aneurysms:clinical and angiographic results in 216 consecutive aneurysms. Stroke. 2010;41(1):110-5.
PubMed
12) Lubicz B, Kadou A, et al. Leo stent for endovascular treatment of intracranial aneurysms:very long-term results in 50 patients with 52 aneurysms and literature review. Neuroradiology. 2017;59(3):271-6.
PubMed
13) Zaidat OO, Hanel RA, et al. Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms:One-Year Outcomes. Stroke. 2020;51(7):2087-94.
PubMed
14) Fiorella D, Boulos A, et al. The safety and effectiveness of the LVIS stent system for the treatment of wide-necked cerebral aneurysms:final results of the pivotal US LVIS trial. J Neurointerv Surg. 2019;11(4):357-61.
 
15) Thorell WE, Chow MM, et al. Y-configured dual intracranial stent-assisted coil embolization for the treatment of wide-necked basilar tip aneurysms. Neurosurgery. 2005;56(5):1035-40;discussion 1035-40.
 
16) Bsat S, Bsat A, et al. Safety of stent-assisted coiling for the treatment of wide-necked ruptured aneurysm:A systematic literature review and meta-analysis of prevalence. Interv Neuroradiol. 2020;26(5):547-56.
PubMed
P.244 掲載の参考文献
1) Velasco A, Buerke B, et al. Comparison of a Balloon Guide Catheter and a Non-Balloon Guide Catheter for Mechanical Thrombectomy. Radiology. 2016;280:169-76.
 
2) Brinjikji W, Starke RM, et al. Impact of balloon guide catheter on technical and clinical outcomes:a systematic review and meta-analysis. J Neurointerv Surg. 2018;10:335-9.
PubMed
3) Yoshimura YS, Enomoto Y, et al. Carotid-compression technique for the insertion of guiding catheters. AJNR Am J Neuroradiol. 2006;27:1710-1.
 
4) Tokunaga S, Tsurusaki Y, et al. Balloon-inflation Anchoring Technique for Insertion of a Guiding Catheter in Acute Mechanical Thrombectomy. JNET J Neuroendvasc Ther. 2017;11(2):53-8.
 
5) Turk AS, Spiotta A, et al. Initial clinical experience with the ADAPT technique:a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg. 2014;6:231-7.
PubMed
6) McTaggart RA, Tung EL, et al. Continuous aspiration prior to intracranial vascular embolectomy(CAPTIVE):a technique which improves outcomes. J Neurointerv Surg. 2017;9:1154-9.
PubMed
7) Maus V, Behme D, et al. Maximizing First-Pass Complete Reperfusion with SAVE. Clin Neuroradiol. 2018;28:327-338.
PubMed
8) Haussen DC, Rebello LC, et al. Optimizating Clot Retrieval in Acute Stroke:The Push and Fluff Technique for Closed-Cell Stentrievers. Stroke. 2015;46;2838-42.
PubMed

VI 疾患の特性と実際の治療法 - 基本手技の応用編 -

P.256 掲載の参考文献
1) Adams HP Jr, Kassell NF, et al. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage:influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology. 1987;37:1586-91.
PubMed
2) Baxter BW, Rosso D, et al. Double microcatheter technique for detachable coil treatment of large, wide-necked intracranial aneurysms. AJNR Am J Neuroradiol. 1998;19:1176-8.
 
3) Brisman JL, Niimi Y, et al. Aneurysmal rupture during coiling:low incidence and good outcomes at a single large volume center. Neurosurgery. 2005;57:1103-9;discussion 1103-1109, 2005.
 
4) Clouston JE, Numaguchi Y, et al. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1995;16:27-38.
PubMed
5) de Oliveira JG, Beck J, et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage:a systematic review and meta-analysis. Neurosurg Rev. 2007;30:22-30;discussion 30-21.
PubMed
6) Dehdashti AR, Mermillod B, et al. Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis. 2004;17:53-60.
PubMed
7) Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128-33.
PubMed
8) Egashira Y, Yoshimura S, et al. Continuous growth of remote intracerebral haematoma following angiographically successful endovascular embolisation of ruptured cerebral aneurysms. J Clin Neurosci. 2012;19:170-3.
 
9) Elijovich L, Higashida RT, et al. Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms:the CARAT study. Stroke. 2008;39:1501-6.
PubMed
10) Imamura H, SakaI N, et al. Endovascular treatment of aneurysmal subarachnoid hemorrhage in Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neurol Med Chir (Tokyo). 2014;54(2):81-90.
 
11) Iwabuchi S, Yokouchi T, et al. Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage:experience of 90 cases. Early Brain Injury or Cerebral Vasospasm. Springer. 2011.
 
12) Kawanabe Y, Sadato A, et al. Endovascular occlusion of intracranial aneurysms with Guglielmi detachable coils:correlation between coil packing density and coil compaction. Acta Neurochir (Wien). 2001;143:451-5.
PubMed
13) Keller E, Krayenbuhl N, et al. Cerebral vasospasm:results of a structured multimodal treatment. Acta Neurochir Suppl. 2005;94:65-73.
PubMed
14) Lim YC, Shim YS, et al. External ventricular drainage before endovascular treatment in patients with aneurysmal subarachnoid hemorrhage in acute period:its relation to hemorrhagic complications. Neurointervention. 2019;14:35.
PubMed
15) McDougall CG, Spetzler RF, et al. The Barrow Ruptured Aneurysm Trial. J Neurosurg. 2012;116:135-44.
 
16) Mocco J, Snyder KV, et al. Treatment of intracranial aneurysms with the Enterprise stent:a multicenter registry. J Neurosurg. 2009;110:35-9.
 
17) Molyneux A, Kerr R, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms:a randomised trial. Lancet. 2002;360:1267-74.
PubMed
18) Molyneux AJ, Birks J, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms:18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385:691-7.
PubMed
19) Moret J, Cognard C, et al. The "Remodelling Technique" in the Treatment of Wide Neck Intracranial Aneurysms. Angiographic Results and Clinical Follow-up in 56 Cases. Interv Neuroradiol. 1997;3:21-35.
PubMed
20) Murayama Y, Malisch T, et al. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms:report on 69 cases. J Neurosurg. 1997;87:830-5.
 
21) Nakahara T, Kutsuna M, et al. Coil embolization of a large, wide-necked aneurysm using a double coil-delivered microcatheter technique in combination with a balloon-assisted technique. Neurol Res. 1999;21:324-6.
PubMed
22) Nguyen TN, Raymond J, et al. Association of endovascular therapy of very small ruptured aneurysms with higher rates of procedure-related rupture. J Neurosurg. 2008;108:1088-92.
PubMed
23) Platz J, Barath K, et al. Disruption of the blood-brain barrier by intra-arterial administration of papaverine:a technical note. Neuroradiology. 2008;50:1035-9.
PubMed
24) Rabinstein AA, Pichelmann MA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage:a comparison between surgical repair and endovascular coil occlusion. J Neurosurg. 2003;98:319-25.
PubMed
25) Roh H, Kim J, et al. Comparison of stent-assisted and no-stent coil embolization for safety and effectiveness in the treatment of ruptured intracranial aneurysms. J Neurosurg. 2019;1:1-7.
PubMed
26) Sadasivan C, Lieber BB, et al. Angiographic quantification of contrast medium washout from cerebral aneurysms after stent placement. AJNR Am J Neuroradiol. 2002;23:1214-21.
PubMed
27) Sakai N, Yoshimura S, et al. Recent trends in neuroendovascular therapy in Japan:analysis of a nationwide survey-Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neurol Med Chir (Tokyo). 2013;54 supple 2:1-8.
 
28) Sluzewski M, van Rooij WJ, et al. Relation between aneurysm volume, packing, and compaction in 145 cerebral aneurysms treated with coils. Radiology. 2004;231:653-8.
PubMed
29) Sluzewski M, van Rooij WJ, et al. Balloon-assisted coil embolization of intracranial aneurysms:incidence, complications, and angiography results. J Neurosurg. 2006;105:396-9.
PubMed
30) Spetzler RF, McDougall CG, et al. The Barrow Ruptured Aneurysm Trial:3-year results. J Neurosurg. 2013;119:146-57.
PubMed
31) Spetzler RF, McDougall CG, et al. Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial. J Neurosurg. 2019;132:771-6.
 
32) Tachibana E, Harada T, et al. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141:13-9.
PubMed
33) Tahtinen OI, Vanninen RL, et al. Wide-necked intracranial aneurysms:treatment with stent-assisted coil embolization during acute (<72 hours) subarachnoid hemorrhage--experience in 61 consecutive patients. Radiology. 2009;253:199-208.
PubMed
34) Tamatani S, Ito Y, et al. Evaluation of the stability of intracranial aneurysms occluded with guglielmi detachable coils. Interv Neuroradiol. 2001;7:143-8.
PubMed
P.286 掲載の参考文献
1) Wieber DO, Whisnant JP, et al. Unruptured intracranial aneurysms:natural history, clinical outcome, and risk of surgical and endovascular treatment. Lancet. 2003;362:103-10.
 
2) Juvela S, Porras M, et al. Natural history of unruptured intracranial aneurysms:Probability of and risk factors for aneurysm rupture. J Neurosurg. 2008;108:1052-60.
PubMed
3) 脳ドックの新ガイドライン作成委員会. 3)無症候性未破裂脳動脈瘤. 脳ドックのガイドライン2008[改訂第3版], 響文社, 札幌, 2008, p53-9.
 
4) Morita A, Fujiwara S, et al. Risk of rupture associated with intra cerebral aneurysms in the Japanese population:a systemic review of the literature from Japan. J Neurosurg. 2005;102:601-6.
 
5) Morita A, Kinno T, et al. The natural history of unruptured cerebral aneurysms in Japanese cohort. N Eng J Med. 2012;366:2473-82.
 
6) Ishibashi T, Y Murayama, et al. Unruptured intracranial aneurysms:incidence of rupture and risk factors. Stroke. 2009;40:313-6.
 
7) Yonekura M. Small unruptured aneurysm verification (SUAVe study, Japan). Neurol Med Chir(Tokyo). 2004;44:213-4.
PubMed
8) Lall RR, Eddleman CS, et al. Unruptured intracranial aneurysms and the assessment of rupture risk based on anatomical and morphological factors/ sifting through the sand od data. Neurosurg Fovus. 2009;26(5):E2.
 
9) 日本脳卒中学会 脳卒中ガイドライン(編). 5-3未破裂脳動脈瘤の治療. 脳卒中治療ガイドライン2015. 協和企画, 東京, 2015, p230-5.
 
10) Komotar R, Mocco J, et al. Guidelines for the surgical treatment of unruptured intracranial aneurysms:The first annual J Lawrence Pool memorial research symptosium-controversies in the management of cerebral aneurysms. Nuerosurgery. 2008;62:183-94.
 
11) Higashida RT, Lahue BJ, et al. Treatment of unruptured intracranial aneurysms:A nationwide assessment of effectiveness. AJNR Am J Neuroradiol. 2007;28:146-51.
PubMed
12) Abe T, Hirohata M, et al. Clinical benefits of rotational 3D angiography in endovascular treatment of ruptured cerebral aneurysm. AJNR Am J Neuroradiol. 2002;23:686-8.
PubMed
13) Kim KS, Fraser JF, et al. Managenment of antiplatelet therapy In patients undergoing neuroendovascular procedures. J Neurosurg. 2018;129:890-905.
 
14) Teteshima S, Murayama Y, et al. Endovascualr treatment of basilar tip aneurysms using Guglielmi detachable coils:Anatomic and clinical outcomes in 73 patients from single institution. Neurosuegery. 2000;47:1332-43.
 
15) Park HK, Horowitz M, et al. Endovascular treatment of paraclinoid aneurysms:Experience with 73 patients. Neurosurgery. 2003;53:14-24.
PubMed
16) Guglielmi G, Vinuela F, et al. Endovascular treatment of 306 anterior communicating artery aneurysms:overall, perioperative results. J Neurosurg. 2009;110:874-9.
PubMed
17) Gonzalez N, Sedrak M, et al. Impact of anatomical features in the endovascular embolization of 181 anterior communicating artery aneurysms. Stroke. 2008;39:2776-82.
PubMed
18) Santillan A, Schwarz J, et al. Stent-assisted coil embolization of anterior commnicating arteru aneurysms using LVIS Jr stent. Interv Neuroradiol. 2019;25:12-20.
PubMed
19) Kim BM, Kim DI, et al. Clinical outcomes and ischemic complication after treatment of anterior choroidal artery aneurysm:Comparison between surgical clipping and endovascular coiling. AJNR Am J Neuroradiol. 2008;29:286-90.
PubMed
20) Kang HS, Kwon BJ, et al. Endovascular coil embolizat5ion of anterior choroidal artery aneurysms. J Neurosurg. 2009;111:963-9.
PubMed
21) Regli L, Uske A, et al. Endovascular coil placement compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms:a consecutive series. J Neurosurg. 1999;90:1025-30.
 
22) Oishi H, Yoshida K, et al. Endovascular treatment with bare platinum coils for middle cerebral artery aneurysms:Neurol Med Chir (Tokyo). 2009;49:287-93.
PubMed
23) Vendrell JF, Menjot N, et al. Endovascular treatment of 174 middle cerebral artery aneurysms:clinical outcome and radiologic results at long-term follow-up. Radiology. 2009;253(1):191-8.
PubMed
24) Bendok BB, Abi-Asad KR, et al. The Hydrogel Endovascular Aneurysm Treatmnent Trial (HEAT). A Randomized Controlled Trial of the Second-Generation Hydrogel coil. Neurosurgery. 2020;86:615-24.
 
25) Meoka R, Nakagawa, et al. stent-assisted coil embolization of unruptured vertebral artery dissecting aneurysms with the low-profile visualized intraluminal support stent, with five technique:Technincal note and case report. Surg Neurol Int. 2019;10:105.
 
26) Brinjikji W, Lanzino G, et al. Endovascular Treatment of Middle Cerebral Artery Aneurysms:A systemic Review and Single-Center Series. Neurosurgery. 2011;68:397-402.
 
27) Murayama Y, Vinula F, et al. Embolization of incidental cerebral aneurysms by using Guglielmi detachable coil system. J Neurosurg. 1999;90:207-14.
 
28) Sluzewski M, Mosch JA, et al. Rupture of intracranial aneurysms during treatment with Guglialmi detachable coils:incidence, outcome, and risk factors. J Neurosurg. 2001;94:238-40.
 
29) Bradac GB, Bergui M, et al. Periprocedural morbidity and mortality by endovascular treatment of cerebral aneurysms with GDC:a retrospective 12-year experience of a single center. Neurosurg Rev. 2007;30:117-26.
PubMed
30) Kwan BJ, Chang HW, et al. Intracraanial aneurysm perforation during endovascular coiling:Impact on clinical outcome, initial occlusion, and recanalization rates. Neurosurgery. 2008;63:576-83.
 
31) Levy E, Koeble CJ, et al. Rupture of intracranial aneuirysms during endovascular coiling:Management and outcomes. Neurosurgery. 2001;49:807-13.
 
32) Cloft HJ, Kallmes FD. Cerebtral aneurysm perforations complicating therapy with Guglielmi detachable coils:A meta-analysis. AJNR Am J Neuroradiol. 2002;23:1806-9.
 
33) Pak HK, Horowitz M, et al. Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol. 2005;26:506-14.
 
34) Soeda A, Sakai N, et al. Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms:Evaluation of 66 consecutive cases with used of diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2003;24:127-32.
PubMed
35) Workman MJ, Cloft HJ, et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol. 2002;23:1568-76.
PubMed
36) Briganti F, Leone G, et al. Endovascular treatment of cerebral aneurysms using flow-diverter devides:A systemic reviwe. Neuroradiol J. 2015;28:365-75.
 
37) Ishi A, Murayama Y, et al. Immediate and midterm outcomes of patients with cerebral aneurysms treated with Matrix1 and Matrix2 coils:A comparative analysis based on a single-center experience in 250 consecutive cases. Neurosurgery. 2008;63:1071-9.
 
38) Linfante I, Delel MJ, et al. Cerecyte versus platinum coils in the treatment of intracranial aneurysms:packing attenuation and clinical and angiographic midterm results. AJNR Am J Neuroradiol. 2009;30:1496-501.
 
39) Fragen KM, HOh BL, et al. Long-term Resutls of Enterprise stent-Assisted Coil of cerebral aneurysms. Nueosurgery. 2012;71:239-44.
 
40) Jankowitz BT, Hanel R, et al. Neuroform Atlas stent system for the treatment of intracranial aneurysm:Primart results of the atlas Humanbitarian Device Exemption Cohot. J Neurointerv Surg. 2019;11:801-6.
 
41) Iosif C, Piotin M, et al. Safety and effectiveness of the low Profile Visualized Intralumina Support (LVIS and LVIS Jr) devices in the endovascular treatment of intracranial aneurysms:results of the TRAIL multicenter obsrtvational study. J Neurointerv Surg. 2018;10:679-87.
 
42) Santillan A, Boddu, et al. LVIS Jr. stent for treatment of intracranial aneurysmsd wih paritent vessel diameter of 2.5mm or less. Interv Neuroradiol. 2018;34:246-53.
PubMed
43) Kallmes DR, Brinjikji W, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms:a pooled analysis of 3 large studies. J Neurosurg. 2017;127:775-80.
 
44) Pierot L, Spelle L, et al. SAFE study(Safety and efficacty Analysis of FRED EMbolic device in aneurysm treatment):1-year clinical and anatomical results. J Neurointerv Surg. 2019;11:184-9.
PubMed
45) Spiotta AM, Derdeyn CP, et al. Results of the ANSWER Trial Using the PulseRider for the Treatmnent of Broad-NEcked, Bifurcation aneurysms. Neurosurgery. 2017;81:56-65.
 
46) Armoiry X, Turjman F, et al. Endovascular Treatment of Intracranial Aneurysms with WEB Device:A systemiv Reviwe of CLinical Outcomes. AJNR Am J Neuroradiol. 2016;37:868-72.
 
P.291 掲載の参考文献
1) 医療機器添付文書等情報検索:独立行政法人医薬品医療機器総合機構. 機械器具(51)医療用嘴管及び体液誘導管, 高度管理医療機器, 中心循環系血管内塞栓促進用補綴材[JMDNコード:35449004]パルスライダー. https://www.info.pmda.go.jp/downfiles/md/PDF/340216/340216_30100BZX00179000_A_01_01.pdf
 
2) Spiotta AM, Derdeyn CP, et al. Results of the ANSWER trial using the PulseRider for the treatment of broad-necked, bifurcation aneurysms. Neurosurgry. 2017;81:56-65.
 
3) Spiotta AM, Chaudry MI, et al. An updated on the adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction trial:1-year safety and angiographic results. AJNR Am J Neuroradiol. 2018;39:848-51.
PubMed
4) Sakai N, Imamura H, et al. PulseRider-assisted coil embolization for treatment of intracranial bifurcation aneurysms:a single-center case series with 24-month follow-up. World Neurosurg. 2019;128:e461-7.
PubMed
5) 日本脳神経外科学会, 日本脳卒中学会, 日本脳神経血管内治療学会. ワイドネック肩分岐部動脈瘤様治療機器適正使用指針. 2020年3月. http://jsnet.website
 
P.301 掲載の参考文献
1) Blanc R. Luna Aneurysm Embolization System for the Treatment of Intracranial Aneurysms:Abstract WFNS Korea:2013.
 
2) Caroff J, Mihalea C, et al. Role of C-Arm VasoCT in the Use of Endovascular WEB Flow Disruption in Intracranial Aneurysm Treatment. AJNR Am J Neuroradiol. 2014;35:1353-7.
PubMed
3) Colla R, Cirillo L, et al. Treatment of Wide-Neck Basilar Tip Aneurysms Using the Web II Device. Neuroradiol J. 2013;26:669-77.
PubMed
4) Ding YH, Lewis DA, et al. The Woven EndoBridge cerebral aneurysm embolization device (WEB II):initial clinical experience. Neuroradiology. 2011;53:599-607.
 
5) Ding YH, Lewis DA, et al. The Woven EndoBridge:a new aneurysm occlusion device. AJNR Am J Neuroradiol. 2011;32:607-11.
PubMed
6) Lubicz B, Mine B, et al. WEB Device for Endovascular Treatment of Wide-Necked Bifurcation Aneurysms. AJNR Am J Neuroradiol. 2013;34:1209-14.
PubMed
7) Lubicz B, Klisch J, et al. WEB-DL Endovascular Treatment of Wide-Neck Bifurcation Aneurysms:Short-and Midterm Results in a European Study. AJNR Am J Neuroradiol. 2014;35:432-8.
 
8) Mine B, Pierot L, et al. Intrasaccular flow-diversion for treatment of intracranial aneurysms:the Woven EndoBridge. Expert Rev Med Devices. 2014;11:315-25.
PubMed
9) Papagiannaki C, Spelle L, et al. Intrasaccular flow disruption with WEB-DL device:report of a prospective series of 83 patients with 85 aneurysms. AJNR Am J Neuroradiol. 2014;35(11):2106-11
 
10) Pierot L, Liebig T, et al. Intrasaccular flow disruption treatment of intracranial aneurysms:preliminary results of a multicenter clinical study. AJNR Am J Neuroradiol. 2012;33:1232-8.
PubMed
11) Pierot L, Cognard C, et al. Endovascular treatment of ruptured intracranial aneurysms:factors affecting mid-term quality anatomic results- analysis in a prospective multicenter series of patients (CLARITY). AJNR Am J Neuroradiol. 2012;33:1475-80.
 
12) Pierot L, Klisch J, et al. Endovascular WEB Flow Disruption in Middle Cerebral Artery Aneurysms:Preliminary Feasibility, Clinical, and Anatomical Results in a Multicenter Study. Neurosurgery. 2013;73:27-34.
 
13) Pierot L, Gholkar A, et al. Role, safety, and efficacy of WEB flow disruption:a review. EJMINT Invited Review. 2014:1419000139(8th May, 2014).
 
14) Struffert T, Lang S, et al. Angiographic C-arm CT visualization of the Woven EndoBridge Cerebral Aneurysm Embolization Device (WEB):First Experience in an Animal Aneurysm Model. Clin Neuroradiol. 2013;24:43-9.
 
15) Wallner AK, Broussalis E, et al. Coiling after Treatment with the Woben EndoBridge Cerebral Aneurysm Embolization Device:Interv Neuroradiol. 2012;18:208-12.
PubMed
16) Pierot L, Costalat V, et al. Safety and efficacy of aneurysm treatment with WEB:results of the WEBCAST study. J Neurosurg. 2016;124:1250-6.
PubMed
17) Pierot L, Gubucz I, et al. Safety and efficacy of aneurysm treatment with the WEB:Results of the WEBCAST 2 study. AJNR. 2017;38:1151-55.
PubMed
18) Fiorella D, Molyneux A, et al. Demographic, procedural and 30-day safety results from the WEB intra-saccular therapy study (WEB-IT). J Neurointerv Surg. 2017;9:1191-6.
PubMed
19) Arthur AS, Molyneux A, et al. The safety and effectiveness of the Woven EndoBridg (WEB) system for the treatment of wide-necked bifurcation aneurysms:final 12-month results of the pivotal WEB intrasaccular therapy (WEB-IT) study. J Neurointervent Surg. 2019;11:924-30.
 
20) Berlis A, Weber W, et al. Is less more? Preliminary results of WEB17 vs WEB21 treated cerebral aneurysms at two centers in Germany. ABC-WIN seminar 15 January 2019.
 
21) Tau N, Sadeh-Gonik U, et al. The Woben EndoBridge (WEB) for endovascular therapy of intracranial aneurysms:Update of a systematic review with meta-analysis. Clin Neurol Neurosurg. 2018;166:110-5.
PubMed
22) van Rooij SBT, van Rooij WJ, et al. WEB treatment of ruptured intracranial aneurysms:a single-center cohort of 100 patients. AJNR. 2017;38:2282-87.
PubMed
23) Lamin S, Patankar T, et al. Acute WEB audit:UK A national audit of the WEB device in the treatment of ruptured aneurysms. ABC-WIN seminar 15 January 2019
 
24) Pierot L, Szikora I, et al. Aneurysmal treatment with WEB in the cumulative population of two prospective, multicenter series:3-year follow-up. J NeuroIntervent Surg. 2020;0:1-6.
 
25) van Rooji SBT, et al. A systematic review and meta-analysis of Woven EndoBridge single layer for treatment in intracranial aneurysms. Interv Neuroradiol. 2020;26:455-60.
 
26) 日本脳神経外科学会, 日本脳卒中学会, 日本脳神経血管内治療学会. ワイドネック肩分岐部動脈瘤様治療機器適正使用指針. 2020年3月. http://jsnet.website
 
P.308 掲載の参考文献
1) Wallace AN, Kayan Y, et al. Pipeline embolization of posterior communicating artery aneurysms associated with a fetal origin posterior cerebral artery. Clin Neurol Neurosurg. 2017;160:83-7.
PubMed
P.332 掲載の参考文献
1) Barrow DL, Alleyne C. Natural history of giant intracranial aneurysms and indications for intervention. Clin Neurosurg. 1995;42:214-44.
PubMed
2) Wehman JC, Hanel RA, et al. Giant cerebral aneurysms:endovascular challenges. Neurosurgery. 1996;59:S125-38.
 
3) Murayama Y, Vinuela F, et al. Bioabsorbable polymeric material coils for embolization of intracranial aneurysms:a preliminary experimental study. J Neurosurg. 2001;94:454-63.
PubMed
4) Niimi Y, Song J, et al. Endovascular treatment of intracranial aneurysms using matrix coils:early experience and midterm follow-up. Stroke. 2006;37:1028-32.
PubMed
5) Ishii A, Murayama Y, et al. Immediate and midterm outcomes of patients with cerebra1aneuysms treated with Matrix 1 and Matrix 2 coils:a comparative analysis based on a single-center experience in 250 consecutive cases. Neurosurgery. 2008;63:1071-7.
PubMed
6) White PM, Lewis SC, et al. HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS trial):procedural safety and operator-assessed efficacy results. AJNR Am J Neuroradiol. 2008;29:217-23.
PubMed
7) Lubicz B, Francois O, et al. Preliminary experience with the enterprise stent for endovascular treatment of complex intracranial aneurysms:potential advantages and limiting characteristics. Neurosurgery. 2008;62:1063-9.
PubMed
8) Benitez RP, Silva MT, et al. Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery. 2004;54:1359-67.
PubMed
9) Zaidat OO, Hanel RA, et al. Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms:One-Year Outcomes. Stroke. 2020;51(7):2087-94.
PubMed
10) Iosif C, Piotin M, et al. Safety and effectiveness of the Low Profile Visualized Intraluminal Support (LVIS and LVIS Jr) devices in the endovascular treatment of intracranial aneurysms:results of the TRAIL multicenter observational study. J Neurointerv Surg. 2018;10:675-81.
PubMed
11) Cagnazzo F, Limbucci N, et al. Y-stent-assisted coiling of wide-neck bifurcation intracranial aneurysms:a meta-analysis. AJNR Am J Neuroradiol. 2019;40:122-8.
PubMed
12) Aydin K, Stracke CP, et al. Long-term outcomes of wide-necked intracranial bifurcation aneurysms treated with T-stent-assisted coiling. J Neurosurg. 2019;6:1-10 (Online ahead of print)
 
13) Lim YC, Shin YS, et al. Flow Diversion via LVIS Blue Stent within Enterprise Stent in Patients with Vertebral Artery Dissecting Aneurysm. World Neurosurg. 2018;117:203-7.
PubMed
14) Chalouhi N, Tjoumakaris S, et al. Coiling of large and giant aneurysms:complications and long-term results of 334 cases. AJNR Am J Neuroradiol. 2014;35:546-52.
PubMed
15) Becske T, Kallmes DF, et al. Pipeline for uncoilable or failed aneurysms:results from a multicenter clinical trial. Radiology. 2013;267:858-68.
 
16) Becske T, Brinjikji W, et al. Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms:Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery. 2017;80:40-8.
 
17) Kallmes DF, Brinjikji W, et al. Aneurysm Study of Pipeline in an Observational Registry (ASPIRe). Interv Neurol. 2016;5:89-99.
 
18) Kallmes DF, Hanel R, et al. International retrospective study of the pipeline embolization device:a multicenter aneurysm treatment study. AJNR Am J Neuroradiol. 2015;36:108-15.
PubMed
19) Kallmes DF, Brinjikji W, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms:a pooled analysis of 3 large studies. J Neurosurg. 2017;127:775-80.
PubMed
20) SAFE study(Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment):1-year clinical and anatomical results. J Neurointerv Surg. 2019;11:184-9.
PubMed
21) Piano M, Valvassori L, et al. FRED Italian Registry:A Multicenter experience with the Flow Re-direction Endoluminal Device for intracranial aneurysms. J Neurosurg. 2020;133:174-81.
 
22) Ishii A, Oishi H. Pipeline-Indications, patient selection, and avoidance of complications. JNET. 2017;11:138-46.
 
23) Peschillo S, Caporlingua A, et al. Endovascular Treatment of Large and Giant Carotid Aneurysms with Flow-Diverter Stents Alone or in Combination with Coils:A Multicenter Experience and Long-Term Follow-up. Oper Neurosurg (Hagerstown). 2017;13:492-502.
PubMed
24) Brinjikji W, Piano M, et al. Treatment of ruptured complex and large/giant ruptured cerebral aneurysms by acute coiling followed by staged flow diversion. J Neurosurg. 2016;125:120-7.
PubMed
25) Siddiqui AH, Abla AA, et al. Panacea or problem:flow diverters in the treatment of symptomatic large or giant fusiform vertebrobasilar aneurysms. J Neurosurg. 2012;116:1258-66.
 
26) Kiyofuji S, Graffeo CS, et al. Meta-analysis of treatment outcomes of posterior circulation non-saccular aneurysms by flow diverters. J Neurointerv Surg. 2018;10:493-9.
PubMed
27) Griessenauer CJ, Mohlenbruch MA, et al. The FRED for Cerebral Aneurysms of the Posterior Circulation:A Subgroup Analysis of the EuFRED Registry. AJNR Am J Neuroradiol. 2020;41:658-62.
PubMed
28) Griessenauer CJ, Enriquez-Marulanda A, et al. Experience with the Pipeline Embolization Device for posterior circulation aneurysms:A multicenter cohort study. Neurosurgery. 2020;87:1252-61.
PubMed
29) Zetchi M, Dmytriw AA, et al. Entry remnants in flow-diverted aneurysms:Does branch geometry influence aneurysm closure? Interv Neuroradiol. 2018;24(6):624-30.
PubMed
30) Fahed R, Darsaut TE, et al. Flow diversion:what can clinicians learn from animal models? Neuroradiology. 2017;59:255-61.
PubMed
31) Cagnazzo F, Perrini P, et al. Treatment of Unruptured Distal Anterior Circulation Aneurysms with Flow-Diverter Stents:A Meta-Analysis. AJNR Am J Neuroradiol. 2019;40:687-93.
PubMed
32) Monteith SJ, Tsimpas A, et al. Endovascular treatment of fusiform cerebral aneurysms with the Pipeline Embolization Device. J Neurosurg. 2014;120:945-54.
 
33) Lv X, Ge H, et al. A systematic review of pipeline embolization device for giant intracranial aneurysms. Neurol India. 2017;65:35-8.
 
34) van Rooij WJ, Sluzewski M, et al. Predictive value of angiographic testing for tolerance to therapeutic occlusion of the carotid artery. AJNR Am J Neuroradiol. 2005;26:175-8.
PubMed
35) Abud DG, Spelle L, et al. Venous phase timing during balloon test occlusion as a criterion for permanent internal carotid artery sacrifice. AJNR Am J Neuroradiol. 2005;26:2602-9.
PubMed
36) Tomura N, Omachi K, et al. Comparison of technetium Tc 99 m hexamethylpropyleneamine oxime single-photon emission tomography with stump pressure during the balloon occlusion test of the internal carotid artery. AJNR Am J Neuroradiol. 2005;26:1937-42.
 
37) Linskey ME, Jungreis CA, et al. Stroke risk after abrupt internal carotid artery sacrifice:accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR Am J Neuroradiol. 1994;15:829-43.
PubMed
38) Okudaira Y, Arai H, et al. Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion:parameters reflecting cerebral perfusion pressure in the acetazolamide test. Stroke. 1996;27:617-21.
PubMed
39) Mathis JM, Barr JD, et al. Temporary balloon test occlusion of the internal carotid artery:experience in 500 cases. AJNR Am J Neuroradiol. 1995;16:749-54.
PubMed
40) Dare AO, Chaloupka JC, et al. Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Sur Neurol. 1998;50:155-6.
 
41) Wang G, Zhang X, et al. A Hybrid Strategy for Patients with Complex Cerebral Aneurysm:STA-MCA Bypass in Combination With Endovascular Embolization. Front Neurol. 2021;11:614601.
 
42) Sturiale CL, De Waure C, et al. Endovascular Treatment of the Posterior Cerebral Artery Aneurysms:Single-Center Experience and a Systematic Review. World Neurosurg. 2016;91:154-62.
 
43) Agnoletto GJ, Meyers PM, et al. A contemporary review of endovascular treatment of wide-neck large and giant aneurysms. World Neurosurg. 2019;130:523-9. e2.
 
44) Cagnazzo F, Mantilla D, et al. Endovascular Treatment of Very Large and Giant Intracranial Aneurysms:Comparison between Reconstructive and Deconstructive Techniques-A Meta-Analysis. AJNR Am J Neuroradiol. 2018;39:852-8.
PubMed
45) Choi JH, Lee KS, et al. Treatment outcomes of large and giant intracranial aneurysms according to various treatment modalities. Acta Neurochir (Wien). 2020;162:2745-52.
PubMed
P.339 掲載の参考文献
1) Arthur AS, Molyneux A, et al. The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms:final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study. J Neurointerv Surg. 2019;11:924-30.
PubMed
2) Becske T, Kallmes DF, et al. Pipeline for uncoilable or ailed aneurysms:results from a multicenter clinical trial. Radiology. 2013;267:858-68.
 
3) Becske T, Potts MB, et al. Pipeline for uncoilable or failed aneurysms:3-year follow-up results. J Neurosurg. 2016;127:81-8.
 
4) Becske T, Brinjikji W, et al. Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms:five-year results of the pipeline for uncoilable or failed aneurysms trial. Neurosurg. 2017;80:40-8.
 
5) Bhogal P, Ganslandt O, et al. The fate of side branches covered by flow diverters-results from 140 patients. World Neurosurg. 2017;103:789-98.
PubMed
6) Brinjikji W, Lanzino G, et al. Risk factors for hemorrhagic complications following pipeline embolization device treatment of intracranial aneurysms:results from the inter national retrospective study of the pipeline embolization device. AJNR Am J Neuroradiol. 2015;36:2308-13.
 
7) Brinjikji W, Murad MH, et al. Endovascular treatment of intracranial aneurysms with flow diverters:a meta-analysis. Stroke. 2013;44:442-7.
PubMed
8) Chow M, McDougall C, et al. Delayed spontaneous rupture of a posterior inferior cerebellar artery aneurysm following treatment with flow diversion:a clinicopathologic study. AJNR Am J Neuroradiol. 2012;33:E46-E51.
PubMed
9) Dai D, Ding YH, et al. Patency of branches after coverage with multiple telescoping flow-diverter devices:an in vivo study in rabbits. AJNR Am J Neuroradiol. 2012;33:171-4.
 
10) Ferns SP, Sprengers MES, et al. Late reopening of adequately coiled intracranial aneurysms:frequency and risk factors in 400 patients with 440 aneurysms. Stroke. 2011;42:1331-7.
PubMed
11) Fiorella D, Molyneux A, et al. Demographic, procedural and 30-day safety results from the WEB Intra-saccular Therapy Study (WEB-IT). J Neurointerv Surg. 2017;9:1191-6.
PubMed
12) Fiorella D, Lylyk P, et al. Curative cerebrovascular reconstruction with the Pipeline embolization device:the emergence of definitive endovascular therapy for intracranial aneurysms. J Neurointerv Surg. 2018;10:i9-18.
PubMed
13) Fischer S, Vajda Z, et al. Pipeline embolization device (PED) for neurovascular reconstruction:initial experience in the treatment of 101 intracranial aneurysms and dissections. Neuroradiology. 2012;54:369-82.
PubMed
14) Hanel RA, Kallmes DF, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device:the PREMIER study 1 year results. J Neurointerv Surg. 2020;12:62-6.
PubMed
15) Hu YC, Deshmukh VR, et al. Histopathological assessment of fatal ipsilateral intraparenchymal hemorrhages after the treatment of supraclinoid aneurysms with the Pipeline Embolization Device:Report of 3 cases. J Neurosurg. 2014;120:365-74.
 
16) Kallmes DF, Ding YH, et al. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007;38:2346-52.
PubMed
17) Kallmes DF, Brinjikji W, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms:a pooled analysis of 3 large studies. J Neurosurg. 2016;127:775-80.
PubMed
18) Kallmes DF, Ding YH, et al. A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol. 2009;30:1153-8.
PubMed
19) Kulcsar Z, Houdart E, et al. Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol. 2011;32:20-5.
PubMed
20) Lylyk P, Miranda C, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device:the Buenos Aires experience. Neurosurgery. 2009;64:632-42;discussion 642-3;quiz N636.
 
21) McAuliffe W, Wycoco V, et al. Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device. AJNR Am J Neuroradiol. 2012;33:164-70.
PubMed
22) McDonald RJ, McDonald JS, et al. Periprocedural safety of Pipeline therapy for unruptured cerebral aneurysms:Analysis of 279 Patients in a multihospital database. Interv Neuroradiol. 2015;21:6-10.
 
23) Nelson PK, Lylyk P, et al. The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol. 2011;32:34-40.
PubMed
24) Oishi H, Teranishi K, et al. Symptomatic very delayed parent artery occlusion after flow diversion stent embolization. Neurol Med Chir (Tokyo). 2016;56:350-3.
PubMed
25) Rangel-Castilla L, Munich SA, et al. Patency of anterior circulation branch vessels after Pipeline embolization:longer-term results from 82 aneurysm cases. J Neurosurg. 2017;126:1064-9.
 
26) Raymond J, Guilbert F, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003;34:1398-403.
PubMed
27) Rouchaud A, Brinjikji W, et al. Delayed hemorrhagic complications after flow diversion for intracranial aneurysms:a literature overview. Neuroradiology. 2016;58:171-7.
PubMed
28) Saatci I, Yavuz K, et al. Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device:a single-center experience with long-term follow-up results. AJNR Am J Neuroradiol. 2012;33:1436-46.
PubMed
29) Szikora I, Turanyi E, et al. Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion:a histopathologic study. AJNR Am J Neuroradiol. 2015;36:1716-20.
PubMed
30) Szikora I, Marosfoi M, et al. Resolution of mass effect and compression symptoms following endoluminal flow diversion for the treatment of intracranial aneurysms. AJNR Am J Neuroradiol. 2013;34:935-9.
PubMed
31) Ye G, Zhang M, et al. Meta-analysis of the efficiency and prognosis of intracranial aneurysm treated with flow diverter devices. J Mol Neurosci. 2016;59:158-67.
PubMed
32) Zhou G, Su M, et al. Efficacy of flow-diverting devices for cerebral aneurysms:a systematic review and meta-analysis. World Neurosurg. 2016;85:252-62.
PubMed
P.346 掲載の参考文献
1) 日本脳神経外科学会, 日本脳卒中学会, 日本脳神経血管内治療学会. 頭蓋内動脈ステント(脳動脈瘤治療用Flow Diverter)適正使用指針第3版(2020年9月).
 
2) Piano M, Valvassori L, et al. FRED Italian Registry:a multicenter experience with the flow re-direction endoluminal device for intracranial aneurysms. J Neurosurg. 2019;133:174-81.
 
3) Pierot L, Spelle L, et al. SAFE study (Safety and efficacy Analysis if FRED Embolic device in aneurysm treatment):1-year clinical and anatomical results. J Neurointerv Surg. 2019;11:184-9.
PubMed
4) Pierot L, Spelle L, et al. Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device:report of SAFE study. J Neurointerv Surg. 2018;10:765-70.
PubMed
5) Killer-Oberpfalzer M, Kocer N, et al. European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms:The European Flow-Redirection Intraluminal Device Study. Am J Neuroradiol. 2018;39:841-7.
PubMed
6) O'Kelly CJ, Krings T, et al. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol. 2010;16:133-7.
PubMed
P.360 掲載の参考文献
1) 山浦晶, 吉本高志, 他. 非外傷性頭蓋内解離性病変の全国調査(第1報), (第2報). 脳卒中の外科. 1998;26:79-95.
 
2) 小野純一, 樋口佳則, 他. 椎骨脳底動脈系頭蓋内動脈解離の全国調査(最終報告)第一報 -概要について-. 脳卒中の外科. 2015;43:245-51.
 
3) Mizutani T, Aruga T, et al. Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms. Neurosurgery. 1995;36:905-13.
PubMed
4) Nakagawa K, Touho H, et al. Long-term follow-up study of unruptured vertebral artery dissection:clinical outcomes and serial angiographic findings. J Neurosurg. 2000;93:19-25.
 
5) 瀧澤克己. 第VII章 特殊な脳動脈瘤C解離性動脈瘤. 上山博康, 宝金清博(編). 脳動脈瘤手術基本技術とその応用. 南江堂, 東京, 2010, p321-5.
 
6) 小林英一. III 部位別, 脳動脈瘤塞栓術の知行合一 椎骨脳底動脈解離性動脈瘤. 大石英則(編). 脳動脈瘤に対する血管内治療の知行合一. メジカルビュー社, 東京, 2017, p244-57.
 
7) 石井暁. 3章 脳動脈瘤の血管内治療(5) 母血管閉塞術. 「超」入門脳血管内治療テクニックの根拠と実際がわかる(第2版). メディカ出版, 大阪, 2018, p160-8.
 
8) Satow T, Ishii D, et al. Endovascular treatment for ruptured vertebral artery dissecting aneurysms:results from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neurol Med Chir (Tokyo). 2014;54(2):98-106.
 
9) Yeung TW, Lai V, et al. Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery. J Neurosurg. 2012;116:882-7.
PubMed
10) Guan J, Li G, et al. Endovascular treatment for ruptured and unruptured vertebral artery dissecting aneurysms:a meta-analysis. J Neurointerv Surg. 2017;9:558-63.
PubMed
11) Mizutani T, Miki Y, et al. Proposed classification of nonatherosclerotic cerebral fusiform and dissecting aneurysms. Neurosurgery. 1999;45:253-60.
PubMed
12) Aihara M, Naito I, et al. Predictive factors of medullary infarction after endovascular internal trapping using coils for vertebral artery dissecting aneurysms. J Neursurg. 2018;129(1):107-13.
 
13) Terakado T, Nakai Y, et al. Stent-jack technique for ruptured vertebral artery dissecting aneurysm involving the origin of posterior inferior cerebellar artery. Neurointervention. 2020;15:84-8.
PubMed
14) Meckel S, Singh TP, et al. Endovascular treatment using predominatly stent-assisted coil embolization and antiplatelet and anticoagulation management of ruptured blood blister-like aneurysms. AJNR Am J Neuroradiol. 2011;32:764-71.
 
15) Bakay L, Sweet WH. Intra-arterial pressures in the neck and brain. Late changes after carotid closure, acute measurements after vertebral closure. J Neurosurg. 1953;10:353-9.
PubMed
16) Cho DY, Kim BS, et al. The fate of unruptured intracranial vertebrobasilar dissecting aneurysm with brain stem compression according to different treatment modalities. AJNR Am J Neuroradiol. 2019;40(11):1924-31.
PubMed
17) 池田剛, 中居康展. III 部位別, 脳動脈瘤塞栓術の知行合一 内頚動脈解離性動脈瘤. 大石英則(編). 脳動脈瘤に対する血管内治療の知行合一. メジカルビュー社, 東京, 2017, p258-269.
 
18) Szmuda T, Sloniewski P, et al. Towards a new treatment paradigm for ruptured blood blister-like aneurysms of the internal carotid artery? A rapid systematic review. J Neurointervent Surg. 2016;8:488-94.
 
19) Mohlenbruch MA, Kizikilic O, et al. Multicenter experience with FRED Jr Flow Re-Direction Endoluminal Device for intracranial aneurysm in small arteries. AJNR Am J Neuroradiol. 2017;38(10):1959-65.
 
20) Mizutani T, Kojima H, et al. Healing process for cerebral dissecting aneurysms presenting with subarachnoid hemorrhage. Neurosurgery. 2004;54:342-8.
PubMed
P.367 掲載の参考文献
1) Fang Y, Zhu D, et al. Treatment of Blood Blister-like Aneurysms with Stent-Assisted Coiling:A Retrospective Multicenter Study. World Neurosurg. 2019;126:e386-e491.
 
2) Mokin M, Chinea A, et al. Treatment of blood blister aneurysms of the internal carotid artery with flow diversion. J Neurointerv Surg. 2018;10:1074-78.
PubMed
3) Zhu D, Yan Y, et al. Safety and Efficacy of Flow Diverter Treatment for Blood Blister-Like Aneurysm:A Systematic Review and Meta-Analysis. World Neurosurg. 2018;118:e79-86.
 
4) Liu LX, Zhang CW, et al. Application of the Willis covered stent in the treatment of blood blister-like aneurysms:a single-center experience and systematic literature review. World Neurosurg. 2019;123:e652-e60.
PubMed
5) Lin J, Liang Y, et al. Endovascular therapy versus intravenous thrombolysis in cervical artery dissection-related ischemic stroke:a meta-analysis. J Neurol. 2020;267:1585-93.
 
6) Asif KS, Lazzaro MA, et al. Endovascular reconstruction for progressively worsening carotid artery dissection. J Neurointerv Surg. 2015;7:32-9.
PubMed
P.383 掲載の参考文献
1) Al-Shahi R, Fang JS, et al. Prevalence of adults with brain arteriovenous malformations:a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002;73:547-51.
PubMed
2) Al-Shahi R, Bhattacharya JJ, et al. Scottish Intracranial Vascular Malformation Study Collaborators. Prospective, population-based detection of intracranial vascular malformations in adults:the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34:1163-9.
PubMed
3) Gross BA, Du R. Natural history of cerebral arteriovenous malformations:a meta-analysis. J Neurosurg. 2013;118:437-43.
PubMed
4) Spetzler RF, Martin NA, et al. Surgical management of large AVM's by staged embolization and operative excision. J Neurosurg. 1987;67:17-28.
 
5) 滝和郎. 脳神経血管内治療の歩み. 第26回 NPO法人日本脳神経血管内治療学会学術総会開催記念DVD, 2010.
 
6) Taki W, Yonekawa Y, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol. 1990;11:163-8.
PubMed
7) Yamashita K, Taki W, et al. Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR Am J Neuroradiol. 1994;15:1103-5.
PubMed
8) Yamahita K, Taki W, et al. A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations. Neuroradiology. 1996;38:S151-6.
 
9) Sadato A, Taki W, et al. Experimental study and clinical use of poly (vinyl acetate) emulsion as liquid embolisation material. Neuroradiology. 1994;36:634-41.
PubMed
10) Takahashi A, Suzuki J. Nonsurgical treatment of AVM. Development of new liquid embolization method. Suzuki J (ed). Advances in Surgery for Cerebral Stroke, Springer-Verlag, Tokyo-Berlin-Heidelberg-New York, 1988, p215-24.
 
11) 半田隆, 根来真, 他. 脳動静脈奇形の血管内手術-塞栓材料の比較検討-. 脳卒中の外科. 1992;20:319-22.
 
12) Brothers MF, Kaufmann JC, et al. n-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology:histopathologic and polymerization time studies. AJNR Am J Neuroradiol. 1989;10:777-86.
PubMed
13) Murayama Y, Vinuela F, et al. Nonadhesive Liquid Embolic Agent for Cerebral Arteriovenous Malformations:Preliminary histopathological studies in swine rete mirabile. Neurosurgery. 1998;43:1164-75.
PubMed
14) Vollherbst DF, Sommer CM, et al. Liquid embolic agents for endovascular embolization:Eevaluation of an established (Onyx) and a novel (PHIL) embolic agent in an in vitro AVM model. Am J Neuroradiol. 2017;38:1377-82.
 
15) Akmangit I, Daglioglu E, et al. Preliminary experience with Squid:A new liquid embolizing agent for AVM, AV fistulas and tumors. Turk Neurosurg. 2014;24:565-70.
PubMed
16) Luesenhop AJ, Gennarelli TA. Anatomical grading of supratentorial arteriovenous malformations for determining operability. Neurosurgery. 1977;1:30-5.
 
17) Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476-83.
PubMed
18) Lawton MT, Kim H, et al. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2011;66:702-13.
 
19) Kim H, Abla AA, et al. Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of lOO9 surgical patients. Neurosurgery. 2015;76:25-33.
 
20) Hafez A, Koroknay-Pal P, et al. The application of the novel grading scale (Lawton-Young grading system) to predict the outcome of brain arteriovenous malformation. Neurosurgery. 2019;84:529-36.
PubMed
21) Spetzler RF, Ponce FA. A 3 -tier classification of cerebral arteriovenous malformations. J Neurosurg. 2011;114:842-9.
PubMed
22) Dumont TM, Kan P, et al. A proposed grading system for endovascular treatment of cerebral arteriovenous malformations:Buffalo score. Surg Neurol Int. 2015;6:3. doi:10.4103/2152-7806.148847.
 
23) Bell DL, Leslie-Mazwi TM, et al. Application of a novel brain arteriovenous malformation endovascular grading scale for transarterial embolization. AJNR Am J Neuroradiol. 2015;36:1303-9.
PubMed
24) Mohr JP, Michael K, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet. 2014;383:614-21.
PubMed
25) Magro E, Gentric JC, et al. Responses to ARUBA:a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg. 2017;126:486-94.
PubMed
26) 高木康志. 脳動静脈奇形治療のエビデンスとリアルワールド. 脳外誌. 2019;28:142-8.
 
27) Hong CS, Peterson EC, et al. Intervention for a randomized trial of unruptured brain arteriovenous malformations (ARUBA) -Eligible patients:An evidence-based review. Clin Neurol Neurosurg. 2016;150:133-8.
PubMed
28) Potts MB, Lau D, et al. UCSF Brain AVM Study Project. Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg. 2015;122:912-20.
PubMed
29) Pulli B, Chapman PH, et al. Multimodal cerebral arteriovenous malformation treatment:a 12-year experience and comparison of key outcomes to ARUBA. J Neurosurg. 2019;doi:10.3171/2019.8.JNS19998.
 
30) Cenzato M, Boccardi E, et al. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien). 2017;159:1059-64.
 
31) Mohr JP, Overbey JR, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA):final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020;19:573-81.
 
32) Derdeyn CP, Zipfel GJ, et al. Management of Brain Arteriovenous Malformations:A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017;48:e200-24.
PubMed
33) Spetzler RF, Wilson CB, et al. Normal perfusion pressure breakthrough theory. Clin Neurosurg. 1978;25:651-72.
PubMed
34) Al-Rodhan NR, Sundt TM Jr, et al. Occlusive hyperemia:a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations. J Neurosurg. 1993;78:167-75.
PubMed
35) Meyers PM, Fifi JT, et al. Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations:results from a prospective post-market study. J Neurointervent Surg. 2021;doi:10.1136/neurintsurg-2020-016830.
 
36) Mimon S, Strauss I, et al. Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC:short-term results. AJNR Am J Neuroradiol. 2010;3:947-54.
 
37) Hemphill JC 3rd, Greenberg SM, et al. Guidelines for the management of spontaneous intracerebral hemorrhage:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032-60.
PubMed
38) 日本脳卒中学会脳卒中ガイドライン委員会. 脳卒中治療ガイドライン2015. 協和企画, 東京, 2015.
 
39) https://www.jsts.gr.jp/img/guideline2015_tuiho2017.pdf
 
40) https://www.jsts.gr.jp/img/guideline2015_tuiho2019_10.pdf
 
41) Mohr JP, Parides MK, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet. 2014;383:614-21.
 
42) 脳ドックのガイドライン2019改訂委員会編. 脳ドックのガイドライン2019. 響文社, 札幌, 2019.
 
43) Vollherbst DF, Chapot R, et al. First clinical multicenter experience with the new Scepter Mini microballoon catheter. J Neurointervent Surg. 2021:261-6.
 
44) Pulli B, Sussman ES, et al. Initial experience with the Scepter Mini dual-lumen balloon for transophthalmic artery embolization of anterior cranial fossa dural arteriovenous fistulae. J Neurointervent Surg. 2020;12:1132-6.
 
P.397 掲載の参考文献
1) Miyachi S, Negoro M, et al. Embolization of arteriovenous malfmations prorior to radiosurgery. Interv Neuroradiol. 2000;6 Suppl 1:131-7.
 
2) Maruyama K, Kawahara N, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146-53.
PubMed
3) Dahl RH, Holtmannspotter M, et al. Snaring of a Glued Microcatheter During Embolization of an Arteriovenous Malformation with N-Butyl Cyanoacrylate. World Neurosurg. 2018;120:343-8.
 
4) Taylor CL, Dutton K, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg. 2004;100(5):810-2.
PubMed
P.406 掲載の参考文献
1) Chaloupka JC, Huddle DC, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol. 1999;20:401-10.
PubMed
2) Katsaridis V, Papagiannaki C, et al. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008;50:589-97.
PubMed
3) Murayama Y, Vinuela F, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations:preliminary histopathological studies in swine rete mirabile. Neurosurgery. 1998;43:1164-75.
PubMed
4) Pamuk AG, Saatci I, et al. A contribution to the controversy over dimethyl sulfoxide toxicity:anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms. Neuroradiology. 2005;47:380-6.
 
5) Panagiotopoulos V, Gizewski E, et al. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol. 2009;30:99-106.
PubMed
6) Santos NC, Figueira-Coelho J, et al. Multidisciplinary utilization of dimethyl sulfoxide:pharmacological, cellular, and molecular aspects. Biochem Pharmacol. 2003;65:1035-41.
PubMed
7) Song DL, Leng B, et al. [Clinical experience of 70 cases of cerebral arteriovenous malformations embolization with Onyx, a novel liquid embolic agent]. Zhonghua Wai Ke Za Zhi. 2007;45:223-5.
PubMed
8) Taki W, Yonekawa Y, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol. 1990;11:163-8.
PubMed
9) van Rooij WJ, Sluzewski M, et al. Brain AVM embolization with Onyx. AJNR Am J Neuroradiol. 2007;28:172-7;discussion 178.
PubMed
10) Weber W, Kis B, et al. Endovascular treatment of intracranial arteriovenous malformations with onyx:technical aspects. AJNR Am J Neuroradiol. 2007;28:371-7.
PubMed
11) Yamashita K, Taki W, et al. A cationic polymer, Eudragit-E, new liquid embolic material for arteriovenous malformations. Neuroradiology. 1996;38Suppl 1:S151-6.
 
12) Yamashita K, Taki W, et al. Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR Am J Neuroradiol. 1994;15:1103-5.
PubMed
13) Mounayer C, Hammami N, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol. 2007;28:518-23.
PubMed
14) Saatci I, Geyik S, et al. Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique:long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg. 2011;115:78-88.
 
15) Koyanagi M, Mosimann PJ, et al. The transvenous retrograde pressure cooker technique for the curative embolization of high-grade brain arteriovenous malformations. J Neurointerv Surg. 2020 Sep 8 (online ahead of print).
 
P.410 掲載の参考文献
1) Elsenouski A, Aletich VA, et al. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx:a meta-analysis. J Neurointerv Surg. 2016;8(3):265-72.
PubMed
2) Iosif C, Mendes GAC, et al. Endovascular transvenous cure for ruptured brain arteriovenous malformations in complex cases with high Spetzler-Matin grades. J Neurosurg. 2015;122:1229-38.
 
3) Lv X, Song C, et al. Transvenous retrograde AVM embolization:indication, techniques, complications and outcomes. Interv Neuroradiol. 2017;23(5):504-9.
PubMed
4) Chen CJ, Norat P, et al. Transvenous embolization of brain arteriovenous malformations:a review of techniques, indications, and outcomes. Neurosurge Focus. 2018;45(1):E13.
 
5) Chapot R, Stracke P, et al. The pressure cooker technique for the treatment of brain AVMs. J Neuroradiol. 2014;41(1):87-91.
PubMed
6) He Y, Ding Y, et al. Safety and efficacy of transvenous embolization of ruptured brain arteriovenous malformation as a last report:A prospective single arm study. AJNR Am J Neuroradiol. 2019;40(10):1744-51.
 
7) Zaki Ghali G, Zaki Ghali MG, et al. Transvenous embolization of arteriovenous malformation. Clin Neurol Neurosurg. 2019;178:70-6.
PubMed
8) Fahed R, Darsaut TE, et al. Transvenous approach for the treatment of cerebral artreiovenous malformation (TATAM):study protocol of a randomised controlled trial. Interv Neuroradiol. 2019;25(3):305-9.
PubMed
P.416 掲載の参考文献
1) Starke RM, Kano H, et al. Stereotactic radiosurgery for cerebral arteriovenous malformations:evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017;126(1):36-44.
 
2) Cohen-Inbar O, Starke RM, et al. Stereotactic Radiosurgery for Brainstem Arteriovenous Malformations:A Multicenter Study. Neurosurgery. 2017;81(6):910-20.
PubMed
3) Kano H, Kondziolka D, et al. Stereotactic radiosurgery for arteriovenous malformations after embolization:a case-control study. J Neurosurg. 2012;117(2):265-75.
PubMed
4) Pollock BE, Flickinger JC, et al. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery. 1998;42(6):1239-44.
PubMed
5) Russell D, Peck T, et al. Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations:a systematic review and meta-analysis. J Neurosurg. 2018;128(5):1338-48.
PubMed
6) Andrade-Souza YM, Ramani M, et al. Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations. Neurosurgery. 2007;60(3):443-51. discussion 451-2.
 
7) Pollock BE, Kondziolka D, et al. Repeat stereotactic radiosurgery of arteriovenous malformations:factors associated with incomplete obliteration. Neurosurgery. 1996;38(2):318-24.
PubMed
8) Shtraus N, Schifter D, et al. Radiosurgical treatment planning of AVM following embolization with Onyx:possible dosage error in treatment planning can be averted. J Neurooncol. 2010;98(2):271-6.
PubMed
9) Nerva JD, Barber J, et al. Onyx embolization prior to stereotactic radiosurgery for brain arteriovenous malformations:a single-center treatment algorithm. J Neurointerv Surg. 2018;10(3):258-67.
PubMed
10) Lee CC, Chen CJ, et al. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization:a case-control study. J Neurosurg. 2015;123(1):126-35.
PubMed
11) Oermann EK, Ding D, et al. Effect of Prior Embolization on Cerebral Arteriovenous Malformation Radiosurgery Outcomes:A Case-Control Study. Neurosurgery. 2015;77(3):406-17. discussion 417.
PubMed
12) Chen CJ, Ding D, et al. Embolization of Brain Arteriovenous Malformations With Versus Without Onyx Before Stereotactic Radiosurgery. Neurosurgery. 2020;29:nyaa370.
 
13) Watanabe Y, Sandhu D, et al. Three-dimensional assessment of the effects of high-density embolization material on the absorbed dose in the target for Gamma Knife radiosurgery of arteriovenous malformations. J Neurosurg. 2016;125(Suppl 1):123-8.
 
14) Alexander MD, Hippe DS, et al. Targeted Embolization of Aneurysms Associated With Brain Arteriovenous Malformations at High Risk for Surgical Resection:A Case-Control Study. Neurosurgery. 2018;82(3):343-9.
PubMed
15) Panni P, Gallotti AL, et al. Impact of flow and angioarchitecture on brain arteriovenous malformation outcome after gamma knife radiosurgery:the role of hemodynamics and morphology in obliteration. Acta Neurochir (Wien). 2020 ;162(7):1749-57.
PubMed
16) Sato K, Matsumoto Y, et al. Complications of Endovascular Treatments for Brain Arteriovenous Malformations:A Nationwide Surveillance. AJNR Am J Neuroradiol. 2020;41(4):669-75.
PubMed
17) Yen CP, Sheehan JP, et al. Hemorrhage risk of cerebral arteriovenous malformations before and during the latency period after GAMMA knife radiosurgery. Stroke. 2011;42(6):1691-6.
PubMed
18) Maruyama K, Kawahara N, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146-53.
PubMed
19) Ding D, Chen CJ, et al. Risk of Brain Arteriovenous Malformation Hemorrhage Before and After Stereotactic Radiosurgery. Stroke. 2019;50(6):1384-91.
PubMed
20) Hasegawa H, Hanakita S, et al. Re-Evaluation of the Size Limitation in Single-Session Stereotactic Radiosurgery for Brain Arteriovenous Malformations:Detailed Analyses on the Outcomes with Focusing on Radiosurgical Doses. Neurosurgery. 2020;86(5):685-96.
PubMed
21) Kano H, Flickinger JC, et al. How to improve obliteration rates during volume-staged stereotactic radiosurgery for large arteriovenous malformations. J Neurosurg. 2018;1:1-8.
PubMed
22) Hanakita S, Shin M, et al. Outcomes of Volume-Staged Radiosurgery for Cerebral Arteriovenous Malformations Larger Than 20cm (3) with More Than 3 Years of Follow-Up. World Neurosurg. 2016;87:242-9.
 
23) Ding D, Yen CP, et al. Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations. J Neurosurg. 2014;120(4):959-69.
PubMed
24) Mohr JP, Parides MK, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614-21.
 
25) Mohr JP, Overbey JR, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA):final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020;19(7):573-81.
 
26) Pierot L, Kadziolka K, et al. Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery. AJNR Am J Neuroradiol. 2013;34(7):1395-400.
PubMed
27) Nataraj A, Mohamed MB, et al. Multimodality treatment of cerebral arteriovenous malformations. World Neurosurg. 2014;82(1-2):149-59.
PubMed
28) Todnem N, Ward A, et al. A Retrospective Cohort Analysis of Hemorrhagic Arteriovenous Malformations Treated with Combined Endovascular Embolization and Gamma Knife Stereotactic Radiosurgery. World Neurosurg. 2019;122:e713-22.
 
P.421 掲載の参考文献
1) Vladimir B, Ondrej B. Brain Arteriovenous Malformations. Pathogenesis, epidemiology, Diagnosis, Treatment and Outcome. Springer, 2017.
 
2) Ota T, Komiyama M. Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications. Interv Neuroradiol. 2020;26:244-53.
PubMed
3) Barresi MJ, Gilbert S. Developmental Biology. 12th ed. Oxford University Press, 2019.
 
4) Nikolaev SI, Vetiska S, et al. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain. N Engl J Med. 2018;378:250-61.
PubMed
5) Hong T, Yan Y, et al. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain. 2019;142:23-34.
PubMed
6) Lekwuttikarn R, Lim YH, et al. Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child. JAMA Dermatol. 2019;155:256-7.
 
7) Chelliah MP, Do HM, et al. Management of complex arteriovenous malformations using a novel combination therapeutic algorithm. JAMA Dermatol. 2018;154:1316-9.
PubMed
P.459 掲載の参考文献
1) Terada T, Higashida RT, et al. Development of acquired arteriovenous fistulas in rats due to venous hypertension. J Neurosurg. 1994;80(5):884-9.
PubMed
2) Terada T, Tsuura M, et al. The role of angiogenic factor bFGF in the development of dural AVFs. Acta Neurochir(Wien). 1996;138(7):877-83.
PubMed
3) Rothbart D, Awad IA, et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996;38(5):915-25.
PubMed
4) Lawton MT, Jacobowitz R, et al. Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg. 1997;87(2):267-74.
PubMed
5) Nishijima M, Takaku A, et al. Etiological evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations. J Neurosurg. 1992;76:600-6.
PubMed
6) Mizutani K, Akiyama T, et al. Intraosseous venous structures adjacent to the jugular tubercle associated with an anterior condylar dural arteriovenous fistula. Neuroradiology. 2018;60(5):487-96.
 
7) Cognard C, Gobin YP, et al. Cerebral dural arteriovenous fistulas:clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194(3):671-80.
PubMed
8) Borden JA, Wu JK, et al. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82(2):166-79.
PubMed
9) Lalwani AK, Dowd CF, et al. Grading venous restrictive disease in patients with dural arteriovenous fistulas of the transverse/sigmoid sinus. J Neurosurg. 1993;79(1):11-5.
PubMed
10) Satomi J, van Dijk JM, et al. Benign cranial dural arteriovenous fistulas:outcome of conservative management based on the natural history of the lesion. J Neurosurg. 2002;97:767-70.
PubMed
11) van Dijk JM, terBrugge KG, et al. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke. 2002;33:1233-6.
PubMed
12) Soderman M, Pavic L, et al. Natural history of dural arteriovenous shunts. Stroke. 2008;30:1735-9.
 
13) Suh DC, Lee JH, et al. New concept in cavernous sinus dural arteriovenous fistula:correlation with presenting symptom and venous drainage patterns. Stroke. 2005;36:1134-9.
PubMed
14) Calzolari F. Unusual termination of the inferior petrosal sinus. Neuroradiology. 2002;44(9):796-7.
PubMed
15) Satow T, Murao K, et al. Superselective shunt occlusion for the treatment of cavernous sinus dural arteriovenous fistulae. Neurosurgery. 2013;73(1 Suppl Operative):ons100-105.
 
16) Kiyosue H, Tanoue S, et al. Shunted pouches of cavernous sinus dural AVFs:evaluation by 3 D rotational angiography. Neuroradiology. 2015;57(3):283-90.
 
17) Nakagawa I, Wada T, et al. A rare brainstem hemorrhage during transvenous embolization of a cavernous dural arteriovenous fistula. J Clin Neurosci. 2012;19(4):589-92.
 
18) Tanoue S, Kiyosue H, et al. Para-cavernous sinus venous structures:anatomic variations and pathologic conditions evaluated on fat-suppressed 3D fast gradient-echo MR images. AJNR Am J Neuroradiol. 2006;27(5):1083-9.
PubMed
19) Kiyosue H, Mori H, et al. Basal cerebral venous drainage from cavernous sinus dural arteriovenous fistulas. Neuroradiology. 2009;51(3):175-81.
PubMed
20) Kim DJ, Kim DI, et al. Results of transvenous embolization of cavernous dural arteriovenous fistula:a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol. 2006;27(10):2078-82.
PubMed
21) Preechawat P, Narmkerd P, et al. Dural carotid cavernous sinus fistula:ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai. 2008;91(6):852-8.
PubMed
22) Wakhloo AK, Perlow A, et al. Transvenous n-butyl-cyanoacrylate infusion for complex dural carotid cavernous fistulas:technical considerations and clinical outcome. AJNR Am J Neuroradiol. 2005;26(8):1888-97.
PubMed
23) Lv X, Jiang C, et al. Percutaneous transvenous packing of cavernous sinus with Onyx for cavernous dural arteriovenous fistula. Eur J Radiol. 2009;71(2):356-62.
 
24) Wang J, Wu HC, et al. Trigeminal Cardiac Reflex Caused by Onyx Embolization of Intracranial Dural Arteriovenous Fistula. Turk Neurosurg. 2016;26(3):325-30.
 
25) Kiyosue H, Tanoue S, et al. Angioarchitecture of transverse-sigmoid sinus dural arteriovenous fistulas:evaluation of shunted pouches by multiplanar reformatted images of rotational angiography. AJNR Am J Neuroradiol. 2013;34(8):1612-20.
PubMed
26) Kerolus MG, Chung J, et al. An Onyx tunnel:reconstructive transvenous balloon-assisted Onyx embolization for dural arteriovenous fistula of the transverse-sigmoid sinus. J Neurosurg. 2018;129(4):922-7.
PubMed
27) Kiyosue H, Hori Y, et al. Treatment of intracranial dural arteriovenous fistulas:current strategies based on location and hemodynamics, and alternative techniques of transcatheter embolization. Radiographics. 2004;24(6):1637-53.
PubMed
28) Sagara Y, Kiyosue H, et al. Selective transvenous embolization combined with balloon sinoplasty for the treatment of intracranial dural arteriovenous fistulas with sinus occlusion. JNET. 2016;10(5):264-71.
 
29) Levrier O, Metellus P, et al. Use of a self-expanding stent with balloon angioplasty in the treatment of dural arteriovenous fistulas involving the transverse and/or sigmoid sinus:functional and neuroimaging-based outcome in 10 patients. J Neurosurg. 2006;104(2):254-63.
PubMed
30) Ernst R, Bulas R, et al. Three cases of dural arteriovenous fistula of the anterior condylar vein within the hypoglossal canal. AJNR Am J Neuroradiol. 1999;20(10):2016-20.
PubMed
31) Okahara M, Kiyosue H, et al. Selective transvenous embolization of dural arteriovenous fistulas involving the hypoglossal canal. Interv Neuroradiol. 2007;13(1):59-66.
PubMed
32) Kiyosue H, Tanoue S, et al. Ocular symptoms associated with a dural arteriovenous fistula involving the hypoglossal canal:selective transvenous coil embolization. Case report. J Neurosurg. 2001;94(4):630-32.
PubMed
33) Lawton MT, Sanchez-Mejia RO, et al. Tentorial dural arteriovenous fistulae:operative strategies and microsurgical results for six types. Neurosurgery. 2008;62(3 suppl 1):110-24.
 
34) Awad IA, Little JR, et al. Intracranial dural arteriovenous malformations:factors predisposing to an aggressive neurological course. J Neurosurg. 1990;72:839-50.
 
35) Lewis AI, Tomsick TA, et al. Management of tentorial dural arteriovenous malformations:transarterial embolization combined with stereotactic radiation or surgery. J Neurosurg. 1994;81:851-9.
PubMed
36) Byrne JV, Garcia M. Tentorial dural fistulas:endovascular management and description of the medial dural-tentorial branch of the superior cerebellar artery. AJNR Am J Neuroradiol. 2013;34(9):1798-804.
PubMed
37) Agid R, Terbrugge K, et al. Management strategies for anterior cranial fossa (ethmoidal) dural arteriovenous fistulas with an emphasis on endovascular treatment. J Neurosurg. 2009;110:79-84.
PubMed
P.467 掲載の参考文献
1) Medtronic. ONYX液体塞栓システムLD添付文書(2019年4月).
 
2) Carlson AP, Taylor CL, et al. Treatment of dural arteriovenous fistula using ethylene vinyl alcohol (onyx) arterial embolization as the primary modality:Short-term results. J Neurosurg. 2007;107:1120-5.
PubMed
3) Nogueira RG, Dabus G, et al. Preliminary experience with onyx embolization for the treatment of intracranial dural arteriovenous fistulas. AJNR Am J Neuroradiol. 2008;29:91-7.
PubMed
4) Cognard C, Januel AC, et al. Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage:New management using Onyx. AJNR Am J Neuroradiol. 2008;29:235-41.
PubMed
5) Stiefel MF, Albuquerque FC, et al. Endovascular treatment of intracranial arteriovenous fistulae using ONYX:a case series. Neurosurgery. 2009;65:132-40.
PubMed
6) Natarajan SK, Ghodke B, et al. Multimodality Treatment of Intracranial Dural Arteriovenous Fistulas in the Onyx Era:a Single Center Experience. World Neurosurg. 2010;73:365-79.
 
7) Sadeh-Gonike U, Magand N, et al. Transarterial Onyx Embolization of Intracranial Dural Fistulas:A Prospective Cohort, Systematic Review, and Meta-Analysis. Neurosurgery. 2018;82(6):854-63.
PubMed
8) 日本脳神経外科学会, 日本血管内治療学会, 日本インターベンショナルラジオロジー学会, 日本脳神経血管内治療学会. 脳神経領域の液体塞栓物質を用いた塞栓術実施基準(2018年8月1日).
 
9) Watanabe S, Nakahara I, et al. Vagal Nerve Palsy After Transarterial Embolization of Transverse- Sigmoid Dural Arteriovenous Fistula Using Onyx. J Stroke Cerebrovasc Dis. 2019;28(2):464-9.
 
10) Lv X, Li Y, et al. Trigeminocardiac reflex in embolization of intracranial dural arteriovenous fistula. AJNR Am J Neuroradiol. 2007;28:1769-70.
PubMed
11) Abud TG, Houdart E, et al. Safety of Onyx Transarterial Embolization of Skull Base Dural Arteriovenous Fistulas from Meningeal Branches of the External Carotids also Fed by Meningeal Branches of Internal Carotid or Vertebral Arteries. Clin Neuroradiol. 2018;28(4):579-84.
PubMed
12) Ogura R, Hasegawa H, et al. A Case of Curative Onyx Embolization for Tentorial dAVF via Low-flow Feeders with Temporary Balloon Occlusion of High-flow Feeders. JNET. 2020;14:112-7.
 
13) Chapot R, Stracke P, et al. The pressure cooker technique for the treatment of brain AVMs. J Neuroradiol. 2014;41(1):87-91.
PubMed
P.473 掲載の参考文献
1) Yabuzaki H, Terada T, et al. A case of transverse-sigmoid sinus dural arteriovenous fistula treated by transarterial and transvenous embolization via the balloon microcatheter with overinflated balloon protection of the torcula. JNET. 2019;13:388-94.
 
2) 寺田友昭, 薮崎肇, 他. Protection balloon catheterを用いた静脈洞温存下の硬膜動静脈シャント塞栓術. JNET. 2020 in press.
 
3) Levrier O, Metellus P, et al. Use of a self-expanding stent with balloon angioplasty in the treatment of dural arteriovenous fistulas involving the transverse and/or sigmoid sinus:functional and neuroimaging-based outcome in 10 patients. J Neurosurg. 2006;104(2):254-63.
PubMed
P.483 掲載の参考文献
1) 桑山直也, 久保道也, 他. わが国における硬膜動静脈瘻の治療の現状. 脳外誌. 2011;20;12-9.
 
2) Hiramatsu M, Sugiu K, et al. Results of 1940 embolizations for dural arteriovenous fistulas:Japanese Registry of Neuroendovascular Therapy (JR-NET3). J Neurosurg. 2020;133:166-73.
 
3) Hiramatsu M, Sugiu K, et al. Angioarchitecture of arteriovenous fistulas at the craniocervical junction:a multicenter cohort study of 54 patients. J Neurosurg. 2018;128:1839-49.
PubMed
4) 田上秀一, 石黒友也, 他. 頚椎動静脈シャント疾患の血管構築に関する検討:全国調査の結果より. 第34回NPO法人日本脳神経血管内治療学会学術総会. 2018.
 
5) 石黒友也. 頚部における脊髄・脊椎の血管解剖の特徴. 第34回NPO法人日本脳神経血管内治療学会学術総会. 2018.
 
6) Kiyosue H, Matsumaru Y, et al. JSNET Spinal AV Shunts Study Group:Angiographic and Clinical Characteristics of Thoracolumbar Spinal Epidural and Dural Arteriovenous Fistulas. Stroke. 2017;48;3215-22.
 
P.502 掲載の参考文献
1) Lasjaunias P, Berenstein A, et al. Spinal and spinal des veines de la moelle. Neurochirurgie 1979;25:28-30. cord arteries and veins. in:Surgical Neurangiography 2nd edition. vol.1 Clinical vascular anatomy and variations. Springer-Verlag, Berlin Heidelberg, 2001, p73-164.
 
2) Tadie M, Hemet J, et al. Le Dispositif protecteur antireflux des veines de la moelle. Neurochirurgie. 1979;25:28-30.
 
3) Hamid M, Fallet-Bianco C, et al. The human lumbar anterior epidural space:morphological comparison in adult and fetal specimens. Surg Radiol Anat. 2002;24:194-200.
PubMed
4) Kim LJ, Spetzler RF. Classification and surgical management of spinal arteriovenous lesions:arteriovenous fistulae and arteriovenous malformations. Neurosurgery. 2006;59(5 Suppl 3):195-201.
 
5) Veznedaroglu E, Nelson PK, et al. Endovascular treatment of spinal cord arteriovenous malformations. Neurosurgery. 2006;59(5 Suppl3):202-9.
 
6) Rodesch G, Lasjaunias P. Spinal cord arteriovenous shunts:from imaging to management. Eur J Radiol. 2003;46:221-32.
PubMed
7) Niimi Y, Berenstein A, et al. Pediatric nonvertebral paraspinal arteriovenous fistulas along the segmental nerve:clinical, imaging, and therapeutic considerations. J Neurosurg. 2005;103:156-62.
PubMed
8) Cullen S, Krings T, et al. Diagnosis and endovascular treatment of pediatric spinal arteriovenous shunts. Neuroimaging Clin N Am. 2007;17:207-21.
PubMed
9) Satomi J, Mount RJ, et al. Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telenagiectasia. Stroke. 2003;34:783-9.
 
10) Krings T, Geibprasert S, et al. Segmental neurovascular syndromes in children. Neuroimaging Clin N Am. 2007;17:245-58.
PubMed
11) Couly G, Coltey P, et al. The angiogenic potentials of the cephalic mesoderm and the origin of brain and head blood vessels. Mech Dev. 1995;53:97-112.
PubMed
12) Etchevers HC, Vincent C, et al. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development. 2001;128:1059-68.
PubMed
13) Torihashi S, Kuwahara M, et al. Gut-like structures from mouse embryonic stem cells as an in vitro model for gut organogenesis preserving developmental potential after transplantation. Stem Cells. 2006;24:2618-26.
 
14) Bhattacharya JJ, Luo CB, et al. Wyburn-Mason or Bonnet-Dechaume-Blanc as cerebrofacial arteriovenous metameric syndromes (CAMS):A new concept and a new classification. Interv Neuroradiol. 2001;7:19-27.
 
15) Rodesch G, Hurth M, et al. Classification of spinal cord arteriovenous shunts:proposal for a reappraisal- The Bicetre experience with 155 consecutive patients treated between 1981 and 1999. Neurosurgery. 2002;51:374-80.
PubMed
16) Kiyosue H, Matusmaru Y, et al. Angiographic and Clinical Characteristics of Thoracolumbar Spinal Epidural and Dural Arteriovenous Fistulas. Stroke. 2017;48:3215-22.
PubMed
17) Goyal M, Willinsky R, et al. Paravertebral Arteriovenous Malformations with Epidural Drainage:Clinical Spectrum, Imaging Features, and Results of Treatment. AJNR Am J Neuroradiol. 1999;20:749-55.
PubMed
18) 高井敬介. 脊髄動静脈シャント疾患の疾患概念と治療-硬膜外動静脈瘻とは-. 脳外誌. 2020;29(6):422-6.
 
19) Asai J, Hayashi T, et al. Exclusively epidural arteriovenous fistula in the cervical spine with spinal cord symptoms:case report. Neurosurgery. 2001;48:1372-5.
PubMed
20) McCutcheon IE, Doppman JL, et al. Microvascular anatomy of dural arteriovenous abnormalities of the spine:a microangiographic study. J Neurosurg. 1996;84:215-20.
PubMed
21) Berenstein A, Lasjaunias P, et al. Spinal arteriovenous malformations. In;Berenstein A, Lasjaunias P, ter Brugge K (eds):Surgical Neuroangiography, 2nd edition Vol2.2. Springler-Verlag Berlin Heidelberg, 2003, p738-847.
 
22) Berenstein A, Lasjaunias P, et al. Spinal dural arteriovenous fistulae. In;Berenstein A, Lasjaunias P, Brugge KG (eds). Surgical Neuroangiography, 2nd edition Vol2.2. Springler-Verlag Berlin Heidelberg, 2003, p849-72.
 
23) Steinmetz MP, Chow MM, et al. Outcome after the treatment of spinal dural arteriovenous fistulae:a contemporary single-institution series and meta-analysis. Neurosurgery. 2004;55:77-87.
PubMed
24) Guillevin R, Vallee JN, et al. N-Butyl 2-Cyanoacrylate Embolization of Spinal Dural Arteriovenous Fistulae:CT Evaluation, Technical Features, and Outcome Prognosis in 26 Cases. AJNR Am J Neuroradiol. 2005;26:929-35.
PubMed
25) Narvid J, Hetts SW, et al. Spinal dural arteriovenous fistulae:clinical features and long-term results. Neurosurgery. 2008;62:159-66.
PubMed
26) Arslan M, Cinar C, et al. Dual-Lumen Balloon Catheter Technique for Onyx Embolization of Spinal Dural Arteriovenous Fistula. J Vasc Interv Neurol. 2019;10(3):34-7.
PubMed
27) Trivelato FP, Salles MT, et. al. Dual-lumen balloon to increase onyx venous penetration in the treatment of spinal dural arteriovenous fistulas. J Neuroradiol. 2018;45:142-6.
 
28) Hida K, Iwasaki Y, et al. Results of the surgical treatment of perimedullary arteriovenous fistulas with special reference to embolization. J Neurosurg. 1999 ;90(Spine 2):198-205.
 
29) Rodesch G, Hurth M, et al. Angio-architecture of spinal cord arteriovenous shunts at presentation. Clinical correlations in adults and children The Bicetre experience on 155 consecutive patients seen between 1981-1999. Acta Neurochir (Wien). 2004;146:217-27.
PubMed
30) Mourier KL, Gobin YP, et al. Intradural perimedullary arteriovenous fistulae:results of surgical and endovascular treatment in a series of 35 cases. Neurosurgery. 1993;32:885-91.
 
31) Rodesch G, Hurth M, et al. Spinal cord intradural arteriovenous fistulae:anatomic, clinical, and therapeutic considerations in a series of 32 consecutive patients seen between 1981 and 2000 with emphasis on endovascular therapy. Neurosurgery. 2005;57:973-83.
 
32) Barrow DL, Colohan AR, et al. Intradural perimedullary arteriovenous fistulas(type IV spinal cord arteriovenous malformations). J Neurosurg. 1994;81:221-9.
PubMed
33) Yasargil MG, Symon L, et al. Arteriovenous malformations of the spinal cord. Adv Tech Stand Neurosurg. 1984;11:61-102.
PubMed
34) Rosenblum B, Oldfield EH, et al. Spinal arteriovenous malformations:a comparison of dural arteriovenous fistulas and intradural AVM's in 81 patients. J Neurosurg. 1987;67:795-802.
PubMed
35) Connolly ES Jr, Zubay GP, et al. The posterior approach to a series of glomus (Type II) intramedullary spinal cord arteriovenous malformations. Neurosurgery. 1998;42:774-85.
PubMed
36) Rodesch G, Hurth M, et al. Embolization of spinal cord arteriovenous shunts:morphological and clinical follow-up and results--review of 69 consecutive cases. Neurosurgery. 2003;53:40-9.
PubMed
37) Hodes JE, Merland JJ, et al. Spinal vascular malformations:endovascular therapy. Neurosurgery Clin N Am. 1994;5:497-509.
 
38) Manke C, Bretschneider T, et al. Spinal metastases from renal cell carcinoma:effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol. 2001;22:997-1003.
PubMed
39) Anson JA, Spetzler RF, et al. Classification of spinal arteriovenous malformations and implications for treatment. BNI Quarterly. 1992;8:2-8.
 
40) Gueguen B, Merland JJ, et al. Vascular malformations of the spinal cord:intrathecal perimedullary arteriovenous fistulas fed by medullary arteries. Neurology. 1987;37:969-79.
PubMed
P.515 掲載の参考文献
1) Kiyosue H, Matsumaru Y, et al. JSNET Spinal AV Shunts Study Group. Angiographic and Clinical Characteristics of Thoracolumbar Spinal Epidural and Dural Arteriovenous Fistulas. Stroke. 2017;48:3215-22.
 
2) Thron A. Vascular anatomy of the spinal cord:basic radioanatomy for diagnostic imaging and spinal cord interventions. New York, NY:Springer Berlin Heidelberg, 2016.
 
3) Marcus J, Schwarz J, et al. Spinal Dural Arteriovenous Fistulas:A Review. Curr Atheroscler Rep. 2013;15:335.
 
4) Krings T, Geibprasert S. Spinal Dural Arteriovenous Fistulas. AJNR Am J Neuroradiol. 2009;30:639.
PubMed
5) Takai K, Komori T, et al. Microvascular Anatomy of Spinal Dural Arteriovenous Fistulas:Arteriovenous Connections and their Relationships with the Dura Mater. J Neurosurg Spine. 2015;23:526-33.
PubMed
6) Mascalchi M, Cosottini M, et al. Posterior spinal artery infarct. Am J Neuroradiol. 1998;19:361-63.
 
7) Kiyosue H, Tanoue S, et al. Spinal Ventral Epidural Arteriovenous Fistulas of the Lumbar Spine:Angioarchitecture and Endovascular Treatment. Neuroradiology. 2013;55:327-36.
PubMed
P.528 掲載の参考文献
1) Sacco RL, Adams R, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Circulation. 2006;113:409-49.
 
2) Yadav JS, Wholey MH, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-501.
PubMed
3) Gurm HS, Yadav JS, et al. SAPPHIRE Investigators:Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358:1572-9.
PubMed
4) SPACE Collaborative Group, Ringleb PA, Allenberg J, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients:a randomised non-inferiority trial. Lancet. 2006;368:1239-47.
 
5) Mas JL, Chatellier G, et al. EVA-3 S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660-71.
 
6) American College of Cardiology Foundation;American Society of Interventional & Therapeutic Neuroradiology;Society for Cardiovascular Angiography and Interventions;Society for Vascular Medicine and Biology;Society of Interventional Radiology, Bates ER, Babb JD, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2007;49:126-70.
 
7) Sundt TM, Whisnant JP, et al. Prospective study of the effectiveness and durability of carotid endarterectomy. Mayo Clinic Proc. 1990;65:625-35.
 
8) McKevitt FM, Randall MS, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg. 2005;29:522-7.
PubMed
9) Dalanis I, Nano G, et al. Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol. 2006;29:519-21.
PubMed
10) Diener HC, Bogousslavsky J, et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH):randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-7.
PubMed
11) Setacci C, Chisci E, et al. Grading carotid intrastent restenosis:a 6-year follow-up study. Stroke. 2008;39:1189-96.
PubMed
12) Yamada K, Kawasaki M, et al. Prediction of silent ischemic lesions after carotid artery stenting using integrated backscatter ultrasound and magnetic resonance imaging. Atherosclerosis. 2010;208:161-6.
PubMed
13) 柏木淳之, 清末一路, 他. Angioguard XPを用いた頚動脈ステント留置術中塞栓性合併症に関する多施設共同研究-MR plaque imageと狭窄長によるハイリスク群の抽出-. JNET. 2008;2:179-87.
 
14) Ogasawara K, Sakai N, et al. Japanese Society for Treatment at Neck in Cerebrovascular Disease Study Group. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting:retrospective review of 4494 patients. J Neurosurg. 2007;107:1130-6.
 
15) Yoshimura S, Kitajima H, et al. Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery. 2009;64(3 Suppl):122-8.
 
16) Hayakawa M, Sugiu K, et al. Effectiveness of staged angioplasty for avoidance of cerebral hyperperfusion syndrome after carotid revascularization. J Neurosurg. 2019;18:1-11.
 
17) International Carotid Stenting Study investigators;Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study):an interim analysis of a randomised controlled trial. Lancet. 2010;375:985-97.
 
18) Brott TG, Hobson RW 2nd, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
PubMed
19) Carotid Stenting Trialists' Collaboration1:Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis:a preplanned meta-analysis of individual patient data. Lancet. 2010;376:1062-73.
 
20) Reiff T, Eckstein HH, et al. Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment:One-year interim results of SPACE-2. Int J Stroke. 2019;15(6):1747493019833017. Online ahead of print.
 
21) Bijuklic K, Wandler A, et al. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting):a prospective randomized trial. J Am Coll Cardiol 2012;59:1383-9.
 
P.544 掲載の参考文献
1) Cremonesi A, et al. Carotid artery stenting:an update. Eur Heart J. 2015;36:13-21.
PubMed
2) Kedev S, et al. Safety of slender 5 Fr transradial approach for carotid artery stenting with a novel nitinol double-layer micromesh stent. Am J Cardiol. 2015;116:977-81.
 
3) Hopf-Jensen S, et al. Initial clinical experience with the micromesh RoadSaver carotid artery stent for the treatment of patients with symptomatic carotid artery disease. J Endovasc Ther. 2015;22:220-5.
PubMed
4) Wissgott C, et al. Preliminary clinical results and mechanical behavior of a new double-layer carotid Stent. J Endovasc Ther. 2015;22:634-9.
 
5) Shindo S, et al. Three-dimensional optical frequency domain imaging evaluation of novel dual-layered carotid stent implantation for vulnerable carotid plaque. J Stroke Cerebrovasc Dis. 2016;25:e31-2.
PubMed
6) Castagno C, et al. Preoperative and postoperative evaluation of new double mesh carotid stents with contrast-enhanced ultrasound and diffusion-weighted imaging. Ann Vasc Surg. 2016;33:228e9-13.
PubMed
7) Bosiers M, et al. The CLEAR-ROAD study:Evaluation of a new dual layer micromesh stent system for the carotid artery. Eurointervention. 2016;12:e672-6.
 
8) Bosiers M, et al. Evaluation of a new dual-layer micromesh stent system for the carotid artery:12-months results from the CLEAR-ROAD study. EuroIntervention. 2018;14:1144-6.
PubMed
9) Nerla R, et al. Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres:clinical results of a multidisciplinary approach. Eurointervention. 2016;12:e677-83.
PubMed
10) Imamura H, et al. Clinical trial of carotied artery stenting using dual-layer CASPER stent for carotid endarterectomy in patients at high and normal risk in the Japanese population. J Neurointer vent Surg. 2020;0:1-6.
 
11) Shoefer J, et al. A prospective, multicenter study of a novel mesh-covered carotid stent. The CGuard CARENET Trial. JACC Cardiovasc Interv. 2015;8:1229-34.
 
12) Musialek P, et al. Novel PARADIGM in carotid revascularisation:Prospective evaluation of All-comer percutaneous carotid revascularisation in symptomatic and increased-risk asymptomatic carotid artery stenosis using CGuard(TM) MicroNet-covered embolic prevention stent system. Eurointervention. 2016;12(5):e658-70.
 
13) Speziale F, et al. Thirty-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard MicroNet-covered Embolic Prevention System in real-world multicenter clinical trial:the IRON-Guard study. EuroIntervention. 2018;13:1714-20.
 
14) Capoccia L, et al. Peri-procedural brain lesions prevention in CAS(3 PCAS):Randomized trial comparing CGuard(TM) stent vs. Wallsitent(TM). Int J Cardiol. 2019;279:148-53.
 
15) Schonholz C, et al. First-in-man implantation of a new hybrid carotid stent to prevent periprocedural neurological events during carotid artery stenting. J Endovasc Ther. 2014;21:601-4.
PubMed
16) Gray AM, et al. Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endoarterectomy:1-year results of the SCAFFOLD trial. Catheter Cardiovasc Interv. 2020;96(1):121-7.
 
17) Runk, et al. Complication rates using Casper dual-layer stents for carotid artery stenting in acute stroke. Clin Neuroradiol Received:14 September 2019 / Accepted:18 November 2019. https://doi.org/10.1007/s00062-019-00860-7
 
18) Yilmatx, et al. Acute occlusions of dual-layer carotid stents after endovascular emergency treatment of tandem lesions. Stroke. 2017;48:2171-5.
PubMed
19) Malik AM, Vora NA, et al. Endovascular treatment of tandem extracranial/intracranial anterior circulation occlusions:preliminary single-center experience. Stroke. 2011;42:1653-7.
PubMed
20) Lockau H, et al. Mechanical thrombectomynin tandem occlusion:procedural considerations and clinical results. Neuroradiology. 2015;57:589-98.
PubMed
21) Yadav JS. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-501.
PubMed
22) Brott TG, et al. Stenting versus endareterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
 
23) Setacci C, et al. Determinants of in-stent restenosis after carotid angioplasty:a case-control study. J Endovasc Ther. 2003;10:1031-8.
PubMed
P.553 掲載の参考文献
1) Stary HC, Chandler AB, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis:A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-74.
 
2) Nighoghossian N, Derex L, et al. The vulnerable carotid artery plaque:Current imaging methods and new perspectives. Stroke. 2005;36:2764-72.
PubMed
3) Renu Virmani R, Ladich RE, et al. Histology of carotid atherosclerotic disease:Neurosurgery. 2006;59:s219-27.
 
4) Polak JF, Shemanski L, et al. Hypoechoic plaque at US of the carotid artery:an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology. 1998;208:649-54.
PubMed
5) Handa N, Matsumoto M, et al. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA Study). Stroke. 1995;26:1781-6.
PubMed
6) Kobayashi E, Ono J, et al. Detection of unstable plaques in patients with carotid stenosis using B-mode ultrasonography. Intervent Neurorad. 2000;6:165-70.
 
7) Henry M, Henry I, et al. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system:Midterm results. J Endovasc Ther. 2002;9:1-13.
PubMed
8) Biasi GM, Froio A, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting:the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004;110:756-62.
PubMed
9) Sztajzel R, Momjian S, et al. Stratified gray-scale median analysis and color mapping of the carotid plaque. Stroke. 2005;36:741-5.
PubMed
10) Kunte H, Schmidt C, et al. Contrast-enhanced ultrasound and detection of carotid plaque neovascularization. Neurology. 2012;79(20):2081.
PubMed
11) Ten Kate GL, van den Oord SC, et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. J Vasc Surg. 2013;57(2):539-46.
PubMed
12) Saam T, Hatsukami TS, et al. The vulnerable or high-risk atherosclerotic plaque:Noninvasive MR imaging for characterization and assessment. Radiology. 2007;244:64-77.
 
13) Zhu G, Hom J, et al. Carotid plaque imaging and the risk of atherosclerotic cardiovascular disease. Cardiovasc Diagn Ther. 2020;10:1048-67.
PubMed
14) Underhill HR, Hatsukami TS, et al. A noninvasive imaging approach to assess plaque severity:the carotid atherosclerosis score. Am J Neuroradiol. 2010;31:1068-75.
PubMed
15) DeMarco JK, Huston J 3 rd. Imaging of high-risk carotid artery plaques:current status and future directions. Neurosurg Focus. 2014;36(1):1-8.
 
16) Xu D, Hippe DS, et al. Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score. JACC Cardiovasc Imaging. 2014;7(4):366-73.
PubMed
17) Qiao Y, Ronen I, et al. Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol. 2007;27:1440-6.
PubMed
18) Yoshimura S, Yamada K, et al. High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke. 2011;42:3132-7.
PubMed
19) Yuan C, Zhang S, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181-5.
PubMed
20) Cai J, Hatsukami TS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque. Circulation. 2005;112:3437-44.
PubMed
21) Saam T, Cai JM, et al. Carotid plaque composition differs between ethno-racial groups:An MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol. 2005;25:611-6.
PubMed
22) Chu B, Ferguson MS, et al. Detection of carotid atherosclerotic plaque ulceration, calcification, and thrombosis by multicontrast weighted magnetic resonance imaging. Circulation. 2005;112:e3-e4.
PubMed
23) Yamada N, Higashi M, et al. Association between signal hyperintensity on T1 -weighted MR imaging of carotid plaques and ipsilateral ischemic events. Am J Neuroradiol. 2007;28:287-92.
PubMed
24) Takaya N, Yuan C, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events:A prospective assessment with MRI - Initial results. Stroke. 2006;37:818-23.
PubMed
25) Saba L, Saam T, et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18:559-72.
PubMed
26) 石橋敏寛, 村山雄一, 他. 頚動脈ステント留置術での血栓塞栓症:MRIによるプラーク性状評価とdistal protection deviceとの関連. J Neuroendovasc Ther. 2009;3:3-9.
 
27) 柏木淳之, 清末一路, 他. Angioguard XPを用いた頚動脈ステント留置術中塞栓性合併症に関する多施設共同研究:MR plaque imageと狭窄長によるハイリスク群の抽出. J Neuroendovasc Ther. 2008;2:179-87.
 
28) Touze E, Toussaint JF, et al. Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components:Consequences for prognosis studies and therapeutic trials. Stroke. 2007;38:1812-9.
PubMed
29) Trivedi RA, Mallawarachi C, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006;26:1601-6.
PubMed
30) Sun J, Zhao XQ, et al. Carotid plaque lipid content and fibrous cap status predict systemic CV outcomes:The MRI substudy in AIM-HIGH. JACC Cardiovasc Imaging. 2017;10:241-9.
PubMed
31) Kamtchum-Tatuene J, Wilman A, et al. Carotid plaque with high-risk features in embolic stroke of undetermined source:Systematic review and meta-analysis. Stroke. 2020;51:311-4.
PubMed
32) Baradaran H, Gupta A. Carotid vessel wall imaging on CTA. Am J Neuroradiol. 2020;41:380-6.
PubMed
33) Baradaran H, Al-Dasuqi K, et al. Association between carotid plaque features on CTA and cerebrovascular ischemia:a systematic review and meta-analysis. Am J Neuroradiol. 2017;38:2321-26.
PubMed
34) Horie N, Morikawa M, et al. Assessment of carotid plaque stability based on the dynamic enhancement pattern in plaque components with multidetector CT angiography. Stroke. 2012;43(2):393-8.
PubMed
35) Nasu K, Tsuchikane E, et al. Accuracy of in vivo coronary plaque morphology assessment:A validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol. 2006;47:2405-12.
PubMed
36) Granada JF, Wallace-Bradley D, et al. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol. 2007;27:387-93.
 
37) Diethrich EB, Pauliina Margolis M, et al. Virtual histology intravascular ultrasound assessment of carotid artery disease:The Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther. 2007;14:676-86.
PubMed
38) Redgrave JNE, Lovett JK, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms the Oxford plaque study. Circulation. 2006;113:2320-8.
 
39) Tawakol A, Migrino RQ, et al. Invivo 18 F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-24.
 
40) Lei-xing X, Jing-jing G, et al. Combined application of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques. J Int Med Res. 2014;42(1):213-23.
PubMed
41) Figueroa AL, Subramanian SS, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features. A comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5:69-77.
 
42) Marnane M, Merwick A, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71:709-18.
PubMed
43) Fernandez-Ortiz A, Jimenez-Borreguero LJ, et al. The progression and early detection of subclinical atherosclerosis (PESA) study:rationale and design. Am Heart J. 2013;166(6):990-8.
PubMed
44) Fernandez-Friera L, Fuster V, et al. Vascular inflammation in subclinical atherosclerosis detected by hybrid PET/MRI. J Am Coll Cardiol. 2019;73:1371-82.
PubMed
45) Kobayashi E. Diagnosis of Carotid Plaque Using FDG-PET. J Neuroendovasc Ther. 2018;12:622-31.
 
46) Ohtani T, Ueda Y, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome:detection of vulnerable patients by angioscopy. J Am Coll Cardiol. 2006;47:2194-200.
 
47) Raffel OC, Tearney, GJ, et al. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol. 2007;27:1820-7.
PubMed
48) Yoshimura S, Kawasaki M, et al. Visualization of internal carotid artery atherosclerotic plaques in symptomatic and asymptomatic patients:A comparison of optical coherence tomography and intravascular ultrasound. Am J Neuroradiol. 2012;33:308-13.
PubMed
49) de Donato G, Setacci F, et al. Optical coherence tomography after carotid stenting:rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013;45(6):579-87.
PubMed
P.559 掲載の参考文献
1) Miyachi S, Taki W, et al. Historical perspective of carotid artery stenting in Japan:Analysis of 8,092 cases in The Japanese CAS survey. Acta Neurochir (Wien). 2012;154:2127-37.
PubMed
2) Egashira Y, Yoshimura S, et al. Real-world Experience of Carotid Artery Stenting in Japan:Analysis of 7,134 Cases from JR-NET1 and 2 Nationwide Retrospective Multi-center Registries. Neurol Med Chir (Tokyo). 2014;54:32-9.
 
3) Yoshimura S, Kitajima H, et al. Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery. 2009;64(3 Suppl):122-9.
 
4) Ogasawara K, Sakai N, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid stenting:retrospective review of 4494 patients. J Neurosurg. 2007;107:1130-6.
PubMed
5) Kaku Y, Yoshimura S, et al. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stenting. AJNR Am J Neuroradiol. 2004;25:1403-8.
PubMed
6) Hayakawa M, Sugiu K, et al. Effectiveness of staged angioplasty for avoidance of cerebral hyperperfusion syndrome after carotid revascularization. J Neurosurg. 2020;132:51-61.
 
7) Yoshimura S, Yamada K, et al. High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke. 2011;42:3132-7.
PubMed
8) Yoshimura S, Kawasaki M, et al. Visualization of internal carotid artery atherosclerotic plaques in symptomatic and asymptomatic patients:a comparison of optical coherence tomography and intravascular ultrasound. AJNR Am J Neuroradiol. 33:308-13.
PubMed
P.568 掲載の参考文献
1) Coward LJ, McCabe DJ, et al. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS):a randomized trial. Stroke. 2007;38:1526-30.
PubMed
2) De Vries JP, Jager LC, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery:long-term results. J Vasc Surg. 2005;41:19-23.
 
3) Lin YH, Juang JM, et al. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents:clinical results and restenosis analysis. J Endovasc Ther. 2004;11:719-26.
PubMed
4) Hatano T, Tsukahara T, et al. Stent placement for atherosclerotic stenosis of the vertebral artery ostium:angiographic and clinical outcomes in 1417 consecutive patients. Neurosurgery. 2011;68:108-16.
 
5) Henry M, Henry I, et al. Percutaneous transluminal angioplasty of the subclavian arteries. Int Angiol. 2007;26:324-40.
PubMed
6) Markus HS, Larsson SC, et al. Stenting for symptomatic vertebral artery stenosis The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89(12):1229-36.
PubMed
7) Markus HS, Larsson SC, et al. Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis:the VIST RCT. Health Technol Assess. 2019;23(41):1-30.
PubMed
8) Parkhutik V, Lago A, et al. Angioplasty and stenting of symptomatic and asymptomatic vertebral artery stenosis:to treat or not to treat. Eur J Neurol. 2009;17(E pub).
PubMed
9) Reavey-Cantwell JF, Fox CW, et al. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery. Neurosurgery. 2009;64:890-6.
 
10) Sixt S, Rastan A, et al. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv. 2009;73:395-403.
 
11) Tsutsumi M, Kazakawa K, et al. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology. 2007;49:865.
 
12) Vajda Z, Miloslavski E, et al. Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents:improved follow-up results. AJNR Am J Neuroradiol. 2009;30:1653-6.
PubMed
13) Weber W, Mayer TE, et al. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol. 2005;56:240-7.
PubMed
P.579 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会 編. 脳卒中治療ガイドライン2015. 協和企画, 東京, 2009, p135.
 
2) Chimowitz MI, Lynn MJ, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-16.
PubMed
3) Samuels OB, Joseph GJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643-6.
PubMed
4) Chimowitz MI, Lynn MJ, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003.
PubMed
5) Derdeyn CP, Chimowitz MI, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS):the final results of a randomised trial. Lancet. 2014;383:333-41.
 
6) Alexander MJ, Zauner A, et al. WEAVE Trial:Final Results in 152 On-Label Patients. Stroke. 2019;50(4):889-94.
PubMed
7) Alexander MJ, Zauner A, et al. The WOVEN trial:Wingspan One-year Vascular Events and Neurologic Outcomes. J Neurointerv Surg. 2020;13(4):307-10.
PubMed
8) 中原一郎. Evidence に基づく治療指針が明らかでない症例の治療頭蓋内動脈狭窄症に対する血管内治療 呈示症例に関する考察. The Mt. Fuji Workshop on CVD. 2008;26:122-6.
 
9) 中原一郎. 【頭蓋内動脈狭窄症】頭蓋内動脈狭窄症に対する血管内治療. 脳外誌. 2009;18:509-18.
 
10) 坂井信幸, 江面正幸, 他. 循環器病研究班編脳血管内治療診療指針 2009 循環器病研究委託費(17公-1)総括研究報告書カテーテルインターベンションの安全性確保と担当医師の教育に関する指針(ガイドライン)作成に関する研究. JNET. 2009;3(Suppl.1):1-78.
 
11) Izumi T, Imamura H, et al. Angioplasty and stenting for intracranial stenosis. Neurol Med Chir (Tokyo). 2014;54:46-53.
 
12) Fiorella DJ, Turk AS, et al. U.S. Wingspan Registry:12-month follow-up results. Stroke. 2011;42:1976-81.
PubMed
13) Izumi T, Nishibori M, et al. Endovascular Therapy for Intracranial Artery Stenosis:Results from the Japanese Registry of Neuroendovascular Therapy (JR-NET) 3. Neurol Med Chir (Tokyo). 2020;60(5):256-63.
 
14) Mori T, Fukuoka M, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19(8):1525-33.
 
15) Terada T, Tsuura M, et al. Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses. Neurosurgery. 2006;59:310-8.
PubMed
16) Shin YS, Kim BM, et al. Wingspan stenting for intracranial atherosclerotic stenosis:clinical outcomes and risk factors for in-stent restenosis. Neurosurgery. 2013;72(4):596-604;discussion.
PubMed
17) Yu SC, Leung TW, et al. Angioplasty and stenting of intracranial atherosclerosis with the Wingspan system:1-year clinical and radiological outcome in a single Asian center. J Neurointerv Surg. 2014;6(2):96-102.
 
18) Vajda Z, Guthe T, et al. Neurovascular in-stent stenoses:treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol. 2011;32(10):1942-7.
PubMed
P.595 掲載の参考文献
1) Broderick JP, Palesch YY, et al. for Interventional Management of Stroke (IMS) III Investigators:Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engle J Med. 2013;368:893-903.
 
2) Ciccone A, Valvassori L, et al. for the SYNTHESIS Expansion Investigators:Endovascular treatment for acute ischemic stroke. N Engle J Med. 2013;368:904-13.
 
3) Kidwell CS, Jahan R, et al. for the MR RESCUE Investigators:A trial of imaging selection and endovascular treatment for ischemic stroke. N Engle J Med. 2013;368:914-23.
 
4) Berkhemer OA, Fransen PSS, et al. for the MR CLEAN Investigators:A Randomised trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11-20.
 
5) Campbell BCV, Mitchell PJ, et al. for the EXTEND-IA Investigators:Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-18.
PubMed
6) Goyal M, Demchuk AM, et al. for the ESCAPE Trial Investigators:Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-30.
PubMed
7) Saver JL, Goyal M, et al. for the SWIFT PRIME Investigators:Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285-95.
PubMed
8) Jovin TG, Chamorro A, et al. for the REVASCAT Trial Investigators:Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015:372:2296-306.
PubMed
9) Goyal M, Menon BK, et al. for the HERMES collaborators:Endovascular thrombectomy large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723-31.
PubMed
10) Turk III AS, Siddiqui A, et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS):a multicenter, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019;393:998-1008.
 
11) Nogueira RG, Jadav AP, et al. for the DAWN Trial Investigators:Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11-21.
 
12) Albers GW, Marks MP, et al. for the DEFUSE3 Investigators:Thrombectomy for stroke 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708-18.
 
13) Kang DH, Hwang YH, et al. Direct thrombus retrieval using the reperfusion catheter of the penumbra system:forced-suction thrombectomy in acute ischemic stroke. AJNR Am J Neuroradiol. 2011;32:283-7.
PubMed
14) Turk AS, Spiotta A, et al. Initial clinical experience with ADAPT technique:A direct aspiration first pass technique for stroke thrombectomy. J Neurointervent Surg. 2014;6:231-7.
 
15) Mokin M, Levy EI, et al. for the SWIFT PRIME Investigators:Predictive value of RAPID assessed perfusion thresholds on final infarct volume in SWIFT PRIME (Solitaire with the intention for thrombectomy as primary endovascular treatment). Stroke. 2017;48:932-8.
PubMed
16) Campbell BCV, Majoie CBL, et al. for the HERMES collaborators:Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy:a meta-analysis of individual patient-level data. Lancet Neurol. 2019;18:46-55.
PubMed
17) Zaidat OO, Castonguay AC, et al. First pass effect:A new measure for stroke thrombectomy devices. Stroke. 2018;49:600-66.
 
18) Colby GP, Baharvahdat H, et al. Increased success of single-pass large vessel recanalization using a combined stentriever and aspiration technique:A single institution study. World Neurosurg. 2019;123:e747-52.
PubMed
19) Menon BK, Hill MD, et al. Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions:meta-analysis of data from the HERMES Collaboration. J Neurointervent Surg. 2019;11:1065-9.
 
20) Matsumoto S, Nishiyama H, et al. Initial clinical experience using two-stage aspiration technique (TSAT) with proximal flow arrest by a balloon guiding catheter for acute ischemic stroke of the anterior circulation. J Neurointervent Surg. 2017;9:1160-5.
 
P.601 掲載の参考文献
1) Lapergue B, Labreuche J, et al. Combined use of contact aspiration and the stent retriever technique versus stent retriever alone for recanalization in acute cerebral infarction:the randomized ASTER 2 study protocol. J Neurointerv Surg. 2020;12:471-6.
PubMed
2) Turk AS, Spiotta A, et al. Initial clinical experience with the ADAPT technique:a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg. 2014;6:231-7.
PubMed
3) McTaggart RA, Tung EL, et al. Continuous aspiration prior to intracranial vascular embolectomy (CAPTIVE):a technique which improves outcomes. J Neurointerv Surg. 2017;9:1154-9.
PubMed
4) Maus V, Behme D, et al. Maximizing First-Pass Complete Reperfusion with SAVE. Clin Neuroradiol. 2018;28:327-38.
PubMed
5) Massari F, Henninger N, et al. ARTS (Aspiration-Retriever Technique for Stroke):Initial clinical experience. Interv Neuroradiol. 2016;22:325-32.
PubMed
6) Goto S, Ohshima T, et al. A Stent-Retrieving into an Aspiration Catheter with Proximal Balloon (ASAP) Technique:A Technique of Mechanical Thrombectomy. World Neurosurg. 2018;109:e468-75.
 
7) Ohshima T, Kawaguchi R, et al. Initial Clinical Experience of Using a Newly Designed Preshaped Microguidewire in Acute Endovascular Thrombectomy. Asian J Neurosurg. 2020;15:241-4.
PubMed
8) Ohshima T, Niwa A, et al. Novel Technique for Detection of Actual Position of Clot During Endovascular Clot Retrieval:Assessment of Microcatheter Withdrawing Angiography. World Neurosurg. 2020;137:229-34.
PubMed
P.607 掲載の参考文献
1) Nogueira RG, Jadhav AP, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11-21.
PubMed
2) Albers GW, Marks MP, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708-18.
PubMed
3) Olivot JM, Mlynash M, et al. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort. Stroke. 2014;45:1018-23.
PubMed
4) Nogueira RG, Haussen DC, et al. Large Volumes of Critically Hypoperfused Penumbral Tissue Do Not Preclude Good Outcomes After Complete Endovascular Reperfusion:Redefining Malignant Profile. Stroke. 2016;47:94-8.
PubMed
5) Hsia AW, Luby M, et al. Rapid Apparent Diffusion Coefficient Evolution After Early Revascularization. Stroke. 2019;50:2086-92.
PubMed
6) Yoshie T, Yu Y, et al. Perfusion Parameter Thresholds That Discriminate Ischemic Core Vary with Time from Onset in Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2020;41:1809-15.
PubMed
7) Leigh R, Knutsson L, et al. Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke. J Cereb Blood Flow Metab. 2018;38:1500-16.
PubMed
8) Menon BK, Qazi E, et al. Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial. Stroke. 2015;46:1239-44.
PubMed
9) Berkhemer OA, Jansen IG, et al. Collateral Status on Baseline Computed Tomographic Angiography and Intra-Arterial Treatment Effect in Patients With Proximal Anterior Circulation Stroke. Stroke. 2016;47:768-76.
PubMed
P.614 掲載の参考文献
1) Martinelli I, Sacchi E, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-7.
PubMed
2) Ferro JM, Canhao P, et al. Prognosis of cerebral vein and dural sinus thrombosis:results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35:664-70.
 
3) Taskin D, Derya U, et al. A Multicenter study of 1144 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2017;26(8):1848-57.
 
4) deVeber G, Andrew M, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-23.
PubMed
5) Deschiens MA, Conard J, et al. Coagulation study, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke. 1996;27:1724-30.
PubMed
6) Ludemann P, Nabavi DG, et al. Factor V Leiden mutation is a risk factor for cerebra venous thrombosis:a case-control study. Of 55 patients. Stroke. 1998;29:2507-10.
 
7) de Bruijn SF, Stam J, et al. Case control study of risk of cerebral sinus thrombosis in oral contraceptive users in correction of who are carriers of hereditary prothrombotic condition. BMJ. 1998;316:586-92.
 
8) Prefferkorn T, Crassard I, et al. Clinical features, course and outcome in deep cerebral venous system thrombosis:an analysis of 32 cases. J Neurol. 2009;256:1839-45.
 
9) de Bruijn SF, Stam J, et al. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. Lancet. 1996;348:1623-5.
PubMed
10) Soleau SW, Schmidt R, et al. Extensive experience with dural sinus thrombosis. Neurosurgery. 2003;52:534-44.
PubMed
11) Irene YL, Peter JM, et al. Imaging predictors of clinical deterioration in cerebral venous thrombosis. J of Clin Neurosci. 2012;19:1525-9.
 
12) 日本脳卒中学会 脳卒中ガイドライン委員(編). 脳卒中治療ガイドライン2015[追補2017]. 協和企画, 東京, 2017.
 
13) de Bruijn SF, Stam J, et al. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-8.
PubMed
14) Einhaupl KM, Villringer A, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
PubMed
15) Nagaraja D, Eao BBS, et al. Randomized control trial of heparin in puerperal cerebral venous/sinus thrombosis. Nimhans J. 1995;13:111-5.
 
16) Jonathan MC, Susanna MZ, et al. Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis:The TO-ACT Randomized Clinical Trial. JAMA Neurology. 2020;77(8):966-73.
 
17) Bousser MG. Cerebral venous thrombosis:nothing, heparin, of local thrombolysis? Stroke. 1999;30:481-3.
PubMed
18) Ferro JM, Bacelar-Nicolau H, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203-13.
 
19) Tsai FY, Higashida RT, et al. Acute thrombosis of the intracranial dural sinus:direct thrombolytic treatment. AJNR Am J Neuroradiol. 1992;13:1137-41.
PubMed
20) Horowitz M, Purdy P, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol. 1995;38:58-67.
PubMed
21) Smith TP, Higashida RT, et al. Treatment of dural sinus thrombosis by urokinase infusion. AJNR Am J Neuroradiol. 1994;15:801-7.
PubMed
22) Spearman MP, Jungreis CA, et al. Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR Am J Neuroradiol. 1997;18:502-6.
 
23) Guo Xb, Guan S, et al. Local Thrombolysis for severe cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2012;33:1187-90.
PubMed
24) Frey JL, Muro GJ, et al. Cerebral venous thrombosis:combined intrathrombus rtPA and intravenous heparin. Stroke. 1999;30:489-94.
PubMed
25) Kim SY, Suh JH, et al. Direct endovascular thrombolytic therapy for dural sinus thrombosis:infusion of alteplase. AJNR Am J Neuroradiol. 1997;18:639-45.
PubMed
26) Misra UK, Kalita J, et al. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis:A randomized controlled trial. Eur J Neurol. 2012;19:1030-6.
 
27) La Barge DV 3rd, Bishop FS, et al. Intrasinus catheter-direct heparin infusion in the treatment of dural venous sinus thrombosis. AJNR Am J Neuroradiol. 2009;30:1672-8.
PubMed
28) Li G, Zeng X, et al. Safety and Validity of mechanical thrombectomy and Thrombolysis on severe cerebral venous sinus thrombosis. Neurosurgery. 2013;72:730-8.
 
29) Ke L, Ming R, et al. Efficacy of stenting in patients with cerebral venous sinus thrombosis-related cerebral venous sinus stenosis. J Neuroingerv Surg. 2019;11(3):307-12.
 
30) Ilyas A, Chen CJ, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis:asystematic review. J Neurointerv Surg. 9(11):1-8.
 
31) Guo XB, Liu S, et al. The clinical analysis and treatment starategy of endovascular treatment for cerebral venous sinus thrombosis combined with intracerebral hemorrhage. Sci Rep. 2020;10(1):22300.
 
32) Ferro JM, Bacelar-Nicolau H, et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28(1):39-44.
PubMed
P.627 掲載の参考文献
1) Shah A, Choudhri O, et al. Preoperative endovascular embolization of meningiomas:update on therapeutic options. Neurosurg Focus. 2015;38:E7.
PubMed
2) Ashour R, Aziz-Sultan A. Preoperative tumor embolization. Neurosurg Clin N Am. 2014;25:607-17.
PubMed
3) Carli DF, Sluzewski M, et al. Complications of particle embolization of meningiomas:Frequency, risk factors, and outcome. AJNR Am J Neuroradiol. 2010;31:152-4.
PubMed
4) Cornelius JF, Saint-Maurice JP, et al. Hemorrhage after particle embolization of hemangioblastomas:comparison of outcomes in spinal and cerebellar lesions. J Neurosurg. 2007;106:994-8.
PubMed
5) Ampie L, Choy W, et al. Safety and outcomes of preoperative embolization of intracranial hemangioblastomas:A systematic review. Clin Neurol Neurosurg. 2016;150:143-51.
PubMed
6) Bendszus M, Monoranu CM, et al. Neurologic complications after particle embolization of intracranial meningiomas. AJNR Am J Neuroradiol. 2005;26:1413-9.
PubMed
7) Bendszus M, Rao G, et al. Is there a benefit of preoperative meningioma embolization? Neurosurgery. 2000;47:1306-11.
 
8) Gore P, Theodore N, et al. The utility of onyx for preoperative embolization of cranial and spinal tumors. Neurosurgery. 2008;62:1204-11.
PubMed
9) Carli DFM, Sluzewski M, et al. Complications of particle embolization of meningiomas:frequency, risk factors, and outcome. AJNR Am J Neuroradiol. 2010;31(1):152-4
PubMed
10) Oka H, Kurata A, et al. Preoperative superselective embolizaiotion of skull-base meningiomas:indication and limitations. J Neurooncol. 1998;40:67-71.
PubMed
11) Singla A, Deshaies EM, et al. Controversies in the role of preoperative embolization in meningioma management. Neurosurg Focus. 2013;35:6E17.
 
12) Wang HH, Luo CB, et al. Preoperative embolization of hypervascular pediatric brain tumors:evaluation of technical safety and outcome. Childs Nerv Syst. 2013;29:2043.
PubMed
13) Nania A, Granata F, et al. Necrosis score, surgical time, and transfused blood volume in patients treated with preoperative embolization of intracranial meningiomas. Analysis of a single-centre experience and a review of literature. Clin Neuroradiol. 2014;24:29-36.
 
14) Ampie L, Choy W, et al. Safety and outcomes of preoperative embolization of intracranial hemangioblastomas:A systematic review. Clin Neurol Neurosurg. 2016;150:143-51.
PubMed
15) Doolittle ND, Miner ME, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy an conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer. 2000;88:637-47.
PubMed
16) Jahnke K, Kraemer DF, et al. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer. 2008;112:581-8.
PubMed
17) Macnealy MW, Newton HB, et al. Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption. J Neurooncol. 2008;90:329-33.
PubMed
18) Knuutinen O, Kuitunen H, et al. Case Report:Chemotherapy in Conjunction With Blood-Brain Barrier Disruption for a Patient With Germ Cell Tumor With Multiple Brain Metastases. Clin Genitourin Cancer. 2018;16(5):e993-e996.
PubMed
19) Imbesi F, Marchioni E, et al. A randomized phase III study:comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas. Anticancer Res. 2006;26:553-8.
PubMed
20) Han Y, Park J-H. Convection-enhanced delivery of liposomal drugs for effective treatment of glioblastoma multiforme. Drug Deliv Transl Res. 2020 4. doi:10.1007/s13346-020-00773-w.
 
21) Alexander BM, Wang M, et al. A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806). J Neurooncol. 2013;111:33-9.
 
22) Yoshida Y, Sanno N, Teramoto A. Multiple pituitary hormone gradients from cavernous sinus sampling in patients with cushing's disease. Acta Neurochir (Wien). 2000;142:1339-44.
PubMed
P.639 掲載の参考文献
1) Baskaya MK, Yuceer N, et al. A false traumatic giant aneurysm of the supraclinoid carotid artery. A case report and review of the literature. Neurol Res. 1996;18:135-9.
PubMed
2) Holmes B, Harbaugh RE. Traumatic intracranial aneurysms:a contemporary review. J Trauma. 1993;35:855-60.
PubMed
3) Parkinson D, West M. Traumatic intracranial aneurysms. J Neurosurg. 1980;52:11-20.
PubMed
4) Mizutani T, Kojima H, et al. Pathological mechanism and three-dimensional structure of the cerebral dissecting aneurysms. J Neurosurg. 2001;94:712-7.
PubMed
5) Paul GA, Shaw CM, et al. True traumatic aneurysm of the vertebral artery. Case report. J Neurosurg. 1980;53:101-5.
PubMed
6) Wilkinson IM. The vertebral artery:extracranial and intracranial structure. Arch Neurol. 1972;27:392-6.
PubMed
7) Buckingham MJ, Crone KR, et al. Traumatic intracranial aneurysms in chidlhood:Two cases and a review of the literature. Neurosurgery. 1988;22:398-408.
 
8) Benoit BG, Wortzman G. Traumatic cerebral aneurysms. Clinical features and natural history. J Neurol Neurosurg Psychiatry. 1973;36:127-38.
PubMed
9) Friedman WA, Day AL, et al. Cervical carotid dissecting aneurysms. Neurosurgery. 1980;7:207-14.
PubMed
10) Theron J, Nelson M, et al. Dynamic digitized cerebral parenchymography. Neuroradiology. 1992;34:361-4.
PubMed
11) Ratinov G. Extradural intracranial portion of carotid artery. Arch Neurol. 1964;10:66-73.
PubMed
12) Komiyama M, Nakajima H, et al. Traumatic Carotid Cavernous Sinus Fistula:Serial Angiographic Studies from the Day of Trauma. AJNR Am J Neuroradiol. 1998;19:1641-4.
 
13) Debrun G, Lacour P, et al. Detachable balloon and calibrated-leak balloon techniques in the treatment of cerebral vascular lesions. J Neurosurg. 1978;49:635-49.
PubMed
P.642 掲載の参考文献
1) 杉山聡, 山田聖一, 他. 慢性硬膜下血腫外膜における血管内皮細胞増殖因子の発現. 脳外誌. 2000;9:796-801.
 
2) Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases:clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo), 2001, 41, 371-81.
PubMed
3) Mandai S, Sakurai M, et al. Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. J Neurosurg. 2000;93:686-8.
PubMed
4) Haldrup M, Ketharanathan B, et al. Embolization of the middle meningeal artery in patients with chronic subdural hematoma- a systemic review and meta-analysis. Acta Neurochir (Wien). 2020;162:777-84.
 
5) 大塚崇史, 伊藤真史, 他. 難治性慢性硬膜下血腫に対し2度の中硬膜塞栓術を行った1例-エンボスフィアとNBCAの再発抑制効果の違い. 脳血管内治療. 2019;4:103-9.
 
6) 根岸弘, 渡辺充, 他. 再発を繰り返す慢性硬膜下血腫の1例. 脳外誌. 2016;25:356-61.
 
7) Jumah F, Osama M, et al. Efficacy and safty of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas:a systemic review and meta-analysis. Acta Neurochir (Wien). 2020;162:499-507.
 
P.655 掲載の参考文献
1) Terada A, Komiyama M, et al. Nationalwide survey of pediatric intracranial arteriovenous shunts in Japan:Japanese Pediatric Arteriovenous Shunts Study (JPAS). J Neurosurg Pediatr. 2018;22:550-8.
 
2) 石黒友也, 小宮山雅樹. 小児の脳血管内治療. No Shinkei Geka. 2013;41:731-42.
 
3) Lasjaunias P, ter Brugge KG, Berenstein A. Introduction and general comments regarding pediatric arteriovenous shunts. In;Surgical Neuroangiography vol.3 Clinical and interventional aspects in children. Springer-Verlag, Berlin, 2006, p27-104.
 
4) 松前光紀, 厚見秀樹, 他. 脳脊髄液運動の新知見. No Shinkei Geka. 2016;44:909-24.
 
5) Lasjaunias P, Chung SM, et al. The management of vein of Galen aneurysmal malformations. Neurosurgery. 2006;59(Suppl 3):S184-94.
 
6) Zerah M, Garcia-Monaco R, et al. Hydrodynamics in vein of Galen malformations. Childs Nerv Syst. 1992;8:111-7.
PubMed
7) Raybaud CA, Strother CM, et al. Aneurysm of the vein of Galen:embryonic considerations and anatomical features relating to the pathogenesis of the malformation. Neuroradiology. 1989;31:109-28.
 
8) Berenstein A, Paramasivam S, et al. Vein of Galen aneurysmal malformation:advances in management and endovascular treatment. Neurosurgery. 2019;84:469-78.
PubMed
9) Lasjaunias P, ter Brugge KG, et al. Dural arteriovenous shunts. In;Surgical Neuroangiography vol.3 Clinical and interventional aspects in children. Springer-Verlag, Berlin, 2006, p389-453.
 
10) Jenny B, Zerah M, et al. Giant dural venous sinus ectasia in neonates, J Neurosurg Pediatr. 2010;5:523-8.
PubMed
11) Barbosa M, Mahadevan J, et al. Dural sinus malformations (DSM) with giant lakes, in neonates and infants. Review of 30 consecutive cases. Intervent Neuroradiol. 2003;9:407-24.
 
12) 石黒友也, 小宮山雅樹, 他. 新生児dural sinus malformation. JNET. 2008;2:222-7.
Medical*Online
13) Hetts SW, Moftakhar P, et al. Pediatric intracranial dural arteriovenous fistulas:age-related difference in clinical features, angioarchitecture and treatment outcome. J Neurosurg Pediatr. 2016;18:602-10.
PubMed
14) Lasjaunias P, ter Brugge KG, Berenstein A. Cerebral arteriovenous fistulas. In;Surgical Neuroangiography vol.3 Clinical and interventional aspects in children. Springer-Verlag, Berlin, 2006, p227-89.
 
15) Hetts SW, Keenan K, et al. Pediatric intracranial nongalenic pial arteriovenous fistulas:clinical features, angioarchitecture, and outcome. AJNR Am J Neuroradiol. 2012;33:1710-9.
PubMed
16) Paramasivam S, Toma N, et al. De novo development of dural arteriovenous fistula after endovascular embolization of pial arteriovenous fistula. J Neurointervent Surg. 2013;5:321-6.
 
17) Krings T, Kim H, et al. Neurovascular manifestations in hereditary hemorrhagic telangiectasia:imaging features and genotype-phenotype correlations. AJNR Am J Neuroradiol. 2015;36:863-70.
PubMed
18) Begbie ME, Wallace GM, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome):a view from the 21th century. Postgrad Med J. 2003;79:18-24.
 
19) Revencu N, Boon LM, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutation. Hum Mutat. 2008;29:959-65.
PubMed
20) Amyere M, Revencu N. Germline loss of function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling. Circulation. 2017;136:1037-48.
 
P.664 掲載の参考文献
1) Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children:a classification based on edothelial characteristics. Plast Reconstr Surg. 1982;69:412-22.
 
2) Enjolras O. Classification and management of the various superficial vascular anomalies:hemangiomas and vascular malformations. J Dermatol. 1997;24:701-10.
PubMed
3) Wassef M, Blei F, et al. Vascular anomalies classification:recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136:e203-14.
 
4) International Society for the Study of Vascular Anomalies 2018 Classification. https://www.issva.org/classification
 
5) LeeBB, Laredo J, et al. Terminology and classification of congenital vascular malformations. Phlebology. 2007;22:249-52.
PubMed
6) 血管腫・血管奇形・リンパ管奇形診療ガイドライン2017(第2版). https://www.marianna-u.ac.jp/va/guidline.html
 
7) Limaya N, Wouters V, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41:118-24.
 
8) Castillo SD, Baselga E, et al. PIK3CA mutations in vascular malformations. Curr Opin Hematol. 2019;26:170-8.
PubMed
9) Luks VL, Kamitani N, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015:166;1048-54.
 
10) Kepper-Noreuil KM, Rios JJ, et al. PIK3CA-related overgrowth spectrum (PROS):diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015:167;287-95.
 
11) Cho SK, Do YS, et al. Arteriovenous malformations of the body and extremities:analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006;13:527-38.
PubMed

書評

最近チェックした商品履歴

Loading...